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ABSTRACT
The pH-low insertion peptide (pHLIP) and pH-low insertion cycle (pHLIC) have been
shown to target cancer cells and inflammation due to the acidic environment present at
those sites. It has been demonstrated that pHLIP’s and pHLIC’s pH dependent behavior
stems from the protonation and deprotonation of aspartic acid (Asp) and glutamic acid
(Glu) residues. A decrease in pH leads to the protonation of Asp/Glu located in
membrane-inserting part of peptides, which increases the overall hydrophobicity of
pHLIP and pHLIC and triggers the insertion across a lipid bilayer.
Despite similarity of pHLIP and pHLIC ability to sense pH at cell surfaces the
mechanisms of peptides insertion into membrane is different. pHLIP, which is a flexible
polymer in solution at high pH, undergoes pH-triggered folding in membrane to
transition from coil to transmembrane helix. pHLIC, which is a rigid cyclic peptide,
undergoes pH-triggered partition into membrane without changes of its structure.
pHLIP peptide insertion occurs in several steps, with a rapid interfacial helix formation
(folding) completed within 100 ms followed by the rate limiting step of peptide insertion
across membrane to form a transmembrane helix. Exit from the bilayer and unfolding is
triggered by deprotonation of Asp/Glu residues induced by pH raise. The reverse process
of unfolding and exit proceeds through different intermediate states. The detailed kinetics
study of pHLIP variants pH-triggered insertion and exit from the membrane of liposomes
allowed to elucidate the molecular mechanism of membrane-associated folding and
unfolding, and design and test new pHLIP variants with tunable pH-dependent properties.

Biophysical investigation of several pH-sensitive and pH-insensitive cyclic peptides led
to the selection of best pHLIC candidate for targeting and imaging of neuroinflammation,
which is associated with development of variety of neurodegenerative diseases.
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PREFACE
This dissertation is written in “Manuscript” format, using the Thesis/Dissertation template
of the University of Rhode Island. There are three manuscripts included in this dissertation,
each of which comprises a chapter. The tables and figures of each manuscript are listed
under the corresponding chapter in the list of tables and figures.

The results of our studies presented in the first two chapters were published in the following
papers:
1. Weerakkody D, Moshnikova A, El-Sayed NS, Adochite RC, Slaybaugh G,
Golijanin J, Tiwari RK, Andreev OA, Parang K, Reshetnyak YK. Novel pHsensitive cyclic peptides. Sci Rep, 2016
2. Vila-Viçosa D, Silva TFD, Slaybaugh G, Reshetnyak YK, Andreev OA,
Machuqueiro M. The membrane-induced pK(a) shifts in wt-pHLIP and its
L16H variant. J Chem Theory Comput, 2018
The final chapter is composed of research that is currently under peer-review.
3. Slaybaugh G, Weerakkody D, Engelman D, Andreev OA, Reshetnyak YK.
Kinetics of pH-triggered pHLIP insertion into membrane and exit, under review
in PNAS
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ABSTRACT
A series of cyclic peptides containing a number of tryptophan (W) and glutamic acid (E)
residues were synthesized and evaluated as pH-sensitive agents for targeting of acidic
tissue and pH-dependent cytoplasmic delivery of molecules. Biophysical studies revealed
the molecular mechanism of peptides action and localization within the lipid bilayer of the
membrane at high and low pHs. The symmetric, c[(WE)4WC], and asymmetric, c[E4W5C],
cyclic peptides translocated amanitin, a polar cargo molecule of similar size, across the
lipid bilayer and induced cell death in a pH- and concentration-dependent manner.
Fluorescently-labelled peptides were evaluated for targeting of acidic 4T1 mammary
tumors in mice. The highest tumor to muscle ratio (5.6) was established for asymmetric
cyclic peptide, c[E4W5C], at 24 hours after intravenous administration. pH-insensitive
cyclic peptide c[R4W5C], where glutamic acid residues (E) were replaced by positively
charged arginine residues (R), did not exhibit tumor targeting. We have introduced a novel
class of cyclic peptides, which can be utilized as a new pH-sensitive tool in investigation
or targeting of acidic tissue.
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INTRODUCTION
Tissue acidity is linked to various pathological states such as ischemia, tumor,
inflammation, arthritis, infection, atherosclerosis and others1–3. Tumor progression and
development is associated with acidosis4–6. Extracellular acidity is established already at
early stages of tumor development, during the avascular phase of carcinoma in situ. As
tumor continues to grow, acidosis is increasing due to the poor blood perfusion, switch of
cancer cells to the glycolytic mechanism of energy production even in the presence of
oxygen and overexpression of carbonic anhydrases (CA)7,8. Adaptations to the highly acidic
microenvironment are critical steps in the transition from an avascular pre-invasive tumor
to a malignant invasive carcinoma. Thus, targeting of acidity might serve as a predictive
marker for tumor invasiveness and disease development. pH is especially lower in the
vicinity of the mem- brane of cancer cells due to the work of proton pumps and
CAIX/CAXII9. Also, pK of protonation of Asp and Glu residues is higher (pK ~ 6–7) near
the surface of the hydrophobic membrane compared to bulk aqueous solution, where pK ~
3–410,11. The most effective pH-sensitive tumor targeting agents should sense pH at the
surface of cancer cells, where it is the lowest12. There are a number of approaches under
development for delivery of imaging and therapeutic agents to diseased tissue in a pHdependent manner. They are based on the use of pH-sensitive polymers, liposomes,
nanoparticles and small molecules13–19. Among peptides, family of pHLIP peptides, linear
peptides of 25–35 residues, which insert into cellular membrane and form transmembrane
helices are used for targeting of acidic tumors of various origins and other acidic diseased
tissues20. Application of cyclic peptides in biological sciences has become a subject of
major interest because of their enhanced enzymatic stability versus linear peptides21.
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Recently we reported the design and synthesis of homochiral L-cyclic peptides containing
arginine (R), tryptophan (W) residues and their application for the nuclear targeting delivery
of anti-HIV drugs, phosphopeptides, anticancer drugs, and siRNA22–24. These peptides
offered several advantages including nuclear delivery of doxorubicin, low cytotoxicity,
biocompatibility, hydrophobic drug entrapment through non-covalent interactions, and
drug delivery through conjugation. Herein, we designed and introduced for the first time
the pH-sensitive negatively charged cyclic peptides and studied their interactions with the
lipid bilayer of liposomal and cellular membranes in vitro and in vivo.

RESULTS
Among the investigated peptides were one linear and six cyclic peptides (Fig. 1 and Table
S1, Supplementary Information). All peptides contained: i) single cysteine (Cys, C) residue
for conjugation purposes, ii) at least one tryptophan (Trp, W) for ability to record
fluorescence signal, iii) 3–5 protonatable glutamic acid (Glu, E) residues to trigger pHdependent interaction with the membrane. Three peptides, c[(WE)3WC], c[(WE)4WC] and
c[(WE)5WC] had 3, 4, and 5 repeating units of WE, respectively, where W and E were
alternating in the cyclic of the peptide. Another peptide, c[(LE)4WC], had leucine (Leu, L)
instead of Trp. The main goal was to investigate the role of aromatic Trp residues in
peptide’s interaction with the membrane. Fifth peptide, c[E4W5C], was an asymmetric; it
had five Trp residues located on one side of the cycle, while four Glu residues were located
on the other side of the cycle. The positively charged cyclic peptide control, c[R4W5C], was
also investigated, where Glu residues were replaced by positively charged arginine (Arg,
R) residues. Finally, we synthesized one linear l(CW(EW)4) 10-residue peptide for the
comparison with the cyclic peptides. The peptides were synthesized by employing
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Fmoc/tBu-based solid phase chemistry. As representative examples, the synthesis of
l(CW(EW)4 and c[(WE)4CW] peptides are depicted in the Scheme (Scheme S1,
Supplementary Information). All peptides were purified (95–99%) by reverse phase HPLC.
Fluorescence and CD spectroscopies were employed to monitor pH-dependent
peptide’s interaction with the lipid bilayer of liposomes (Figures S1 and S2, Table S2).
Biophysical studies were carried out at pH 8 and pH 3 to ensure completeness of the
transitions, and to perform measurements in the states of thermodynamic equilibrium. All
peptides demonstrated pH-dependent partitioning into the membrane. Asymmetric cyclic
peptide with Trp residues located on one side of the cycle, c[E4W5C], most probably
partitioned into the membrane facing Trp residues into the bilayer and exposing charged
Glu residues to the extracellular space. The drop of pH led to the protonation of carboxyl
groups of Glu residues, which increased peptides hydrophobicity and promoted further
partitioning of the peptides into the bilayer. As a result, positions of maximum of
fluorescence spectra shifted to 6–9 nm to short wavelengths, which is indicative of changes
of microenvironment of Trp residues from polar to hydrophobic25,26 (Figure S1 and Table
S2). c[(WE)3WC], c[(WE)4WC] and c[(WE)5WC] peptides showed similar CD signals at
pH 8, which were altered by interaction with lipid bilayer and drop of pH. The CD signal
of c[E4W5C] peptide was different but was also pH-dependent. We did not observe
characteristic CD signal of exciton (delocalized, shared electron density) with a
characteristic minimum at 232–235 nm27. Such an exciton might be formed only in a result
of stacking of aromatic amino acids due to the cyclic peptide’s aggregation to form tubular
structures. Thus, we concluded that at the concentrations of the peptides used in this study,
the formation of tubular structures is unlikely.
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By monitoring shift of the position of the maximum of fluorescence spectra for the
peptides in the result of the pH drop, we established apparent pK of peptide’s partitioning
into the bilayer. The pK for most cyclic and linear peptides varied in the range of 5.7–6.4,
while the smallest pK value was observed for the cyclic Leu-containing peptide,
c[(LE)4WC] (Fig. 2).
To establish localization of the peptides within a lipid bilayer of membrane, dual
quenching assay28 was employed (Fig. 3 and Table S3). Effective quenching of
fluorescence by acrylamide would occur only for tryptophan residues exposed to polar
parts of the outer or inner leaflets of the bilayer. At the same time, tryptophan residues
located in the middle of a membrane would be effectively quenched by 10-DN. The result
of the dual quenching assay allows establishing if tryptophan residues were located in the
middle of a membrane or close to the polar headgroups of the bilayer. However, it does not
allow distinguishing between locations

at the outer or inner leaflets of the bilayer.

Therefore, we also performed Förster resonance energy transfer (FRET) assay29 (Fig. 4).
First, symmetrically-labelled by NBD dye, POPC liposomes were prepared. Then,
membrane-impermeable dithionite was used to chemically modify exposed NBD, which
led to the quenching of NBD fluorescence. Thus, NBD dyes located at the outer leaflet of
the bilayer were deactivated and excess of dithionite was removed by gel filtration. As a
result, asymmetrically-labelled liposomes with active NBD at the inner leaflet were
obtained. FRET was monitored from tryptophan residues of the peptides to NBD. Energy
transfer might occur only when both fluorophores are in proximity to each other (within 5–
15 Å). Thus, when tryptophan residues located at the outer leaflet of the bilayer no
significant energy transfer to NBD at the inner leaflet would occur (the distance is about
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50–60 Å). The c[E4W5C] demonstrated the highest quenching by 10-DN and the highest
FRET at pH 8 indicating the internal position of Trp residues within the bilayer of a
membrane. All other peptides were located at the outer leaflet of the bilayer at pH 8. Drop
of pH promoted partitioning of all cyclic peptides into bilayer, which highest FRET for the
c[E4W5C] at pH 3. Among c[(WE)3WC], c[(WE)4WC] and c[(WE)5WC] peptides, the
peptide with the smallest cycle, c[(WE)3WC], showed the deeper partitioning into the
membrane. Linear peptide, l(CW(EW)4), also demonstrated some partitioning into bilayer
in the result of the pH drop.
Since all peptides exhibited pH-dependent interactions with the lipid bilayer of
membrane and no cytotoxicity was observed (Figure S3), we proceeded to the experiments
on cultured cancer cells. Symmetric, c[(WE)4WC], and asymmetric, c[E4W5C], cyclic
peptides were evaluated for their ability to move polar cargo across the membrane. The
experiments on live cells were performed at physiologically relevant pHs, such as pH 7.4
(extracellular pH of normal cells) and pH 6.0 (extracellular pH in the vicinity of cancer
cells12). As a polar cargo, we used amanitin, which is a cell-impermeable cyclic peptide of
molecular mass similar to the masses of investigated pH-sensitive cyclic peptides.
Amanitin is a deadly toxin, which inhibits RNA polymerase II if transferred across the lipid
bilayer of the plasma membrane30. The pH- and concentration-dependent cell death was
observed after treatment of HeLa cells for just 3 hours with c[(WE)4WC]-S-S-amanitin
(c[(WE)4WC]-SPDP-amanitin) and c[E4W- 5C]-S-S-amanitin (c[E4W5C]-SPDP-amanitin)
(Fig. 5a,b). The calculated IC50 values for symmetric cyclic pep- tide amanitin construct,
c[(WE)4WC]-S-S-amanitin, at pH 7.4 and 6.0 were 3.39 ± 0.12 μM and 1.06 ± 0.02 μM,
respectively. The calculated IC50 values for asymmetric cyclic peptide amanitin
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construct, c[E4W5C]-S-S-amanitin, at pH 7.4 and 6.0 were 1.68 ± 0.13 μM and 0.74 ± 0.08
μM, respectively. Previously we showed that amanitin alone does not induce cell death at
the concentrations used in this study and for the duration of treatment of 2–4 hours31. We
also tested construct, where amanitin was conjugated to the asymmetric c[E4W5C] cyclic
peptide via non-cleavable bond (c[E4W5C]-GMBS-amanitin) (Fig. 5c). The cytotoxic effect
for the non-cleavable construct was reduced significantly at both pHs. It might indicate that
the peptide-amanitin construct remained within the membrane and cleavage of amanitin
from the peptide was required to allow amanitin to reach RNA polymerase II in the nucleus.
Alternatively, if peptide-amanitin was translocated into the cytoplasm, the cleavage of
amanitin might be required, since affinity of the peptide-amanitin to the RNA polymerase II
might be reduced compared to the affinity of free amanitin to the RNA polymerase II.
Based on the obtained results, we proposed that at high/normal pH cyclic peptides
were located at the outer leaflet of the bilayer. Triggered by pH drop the protonation of Glu
residues enhanced peptide’s hydrophobicity and induced partitioning of the peptides into
the bilayer of the membrane. This assumption was further con- firmed by quenching of
fluorescence of FITC-labelled asymmetric cyclic peptide by cell impermeable Trypan Blue
(Fig. 5d). Trypan Blue is used to quench fluorescence of FITC located in the extracellular
space32. Cells treated with the FITC-labelled peptide at low pH followed by Trypan Blue
quenching showed higher fluorescent signal on cells opposed to the cells treated with the
FITC-labelled peptide at normal pH followed by Trypan Blue quenching. It indicates that
at normal pH FITC is more exposed to extracellular space (to Trypan Blue) in contrast to
low pH treatment. Since FITC fluorescence is a pH-sensitive and significantly quenched
at low pH (pH 5.0–5.5) in endosomal compartment, we concluded that the FITC-labelled
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peptide was localized at the inner leaflet of the plasma membrane rather than in endosomes.
Also, the cellular uptake of Alexa546-labelled c[E4W5C] peptide at normal and low pHs in
presence and absence of FBS was investigated (Fig. 5e). We observed statistically
significant difference in cellular uptake of peptide at normal and low pHs, and no reduction
of the uptake in the presence of FBS.
Next we proceeded to animal studies to identify the lead peptide demonstrating best
tumor targeting. The murine 4T1 xenograft model, which closely mimics stage IV of
human breast cancer33,34, was used in our study. Small 4T1 tumor (tumor volume <150
mm3) generates a significant level of lactate and serves as a good model of an aggressive,
acidic tumor35. All peptides were covalently conjugated with Alexa546-malemide. The
fluorescent constructs were given as a single IV injection, and at 4 hours after
administration, animals were euthanized followed by necropsy. The mean fluorescence of
tumor, muscle, kidney, liver and lungs were recorded and analyzed (Fig. 6). The least
targeting was observed for Leu-containing peptide, c(LE)4CW. At the same time, the
highest tumor targeting was monitored for linear peptide, l(CW(EW)4), symmetric,
c[(WE)4WC], and asymmetric, c[E4W5C], cyclic peptides.
To prove pH-dependent tumor targeting of WE cyclic peptides we tested positivelycharged asymmetric cyclic peptide, c[R4W5C], where Glu residues were replaced by Arg
residues. This WR-peptide interacted with the lipid bilayer of the membrane at high pH
(Figure S4) due to the presence of Trp residues, similar to WE-peptide. At the same time,
it does not exhibit pH-dependent changes in interaction with the lipid bilayer of membrane,
thus it can serve as a pH-insensitive control for pH-sensitive WE-cyclic asymmetric
peptide, c[E4W5C].
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We performed side-by-side 4T1 tumor targeting and biodistribution investigation
of asymmetric pH-sensitive, c[E4W5C], and pH-insensitive, c[R4W5C], peptides. A
significant difference in tumor targeting was observed at all-time points after IV
administration of the constructs (Figs 7a and S5). It resulted in a significant difference
between tumor/organ ratios for pH-sensitive and insensitive peptides (Fig. 7b and Table
S4). The accumulation of the pH-insensitive peptide in tumor and other organs was very
minimal and varied in the range of 0.8 to 1.6 values, which could be attributed to the passive
diffusion with blood flow. We have introduced a novel class of cyclic peptides, which
demonstrate pH-sensitive interaction with lipid bilayer of membrane of liposomes, cultured
cancer cells and tumors in animal model. We tested six cyclic peptides of three different
cycle sizes, and different localization of Trp, Glu, Leu and Arg residues within the cycles.
The size of investigated peptides is an optimal for the straightforward synthesis. The
significantly smaller or larger sized cycles are more challenging to synthesize. The
interaction of cyclic peptides with lipid bilayer of membrane has different mechanism
compared to the action of linear pH-sensitive peptides such as pHLIP peptides. Negatively
charged Glu residues of cyclic peptides, especially asymmetric one, which showed the best
pH-dependent performance, are exposed to the aqueous solution at normal pH. At the same
time, indole rings of Trp residues most probably interact with the lipid headgroups (Figs 8
and S6). It was demonstrated previously that aromatic Trp residues have high affinity to
lipid headgroups11,36–39. Our biophysical titration data indicate that c[E4W5C] cyclic
peptide partitions into the lipid bilayer at pH 8. About 7.3 kcal/mol of free energy is
released during the process (Figure S7), which indicates on strong interactions of the
peptide with the membrane. The high affinity of the peptides to the cellular membranes at
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normal pH might explain long time of circulation in mice. When pH is lowered, Glu
residues are protonated. The pK of Glu residue protonation in the vicinity of the
hydrophobic membrane is higher compared to the pK in a solution. Protonation leads to
the increase of hydrophobicity of the peptide, which promotes partitioning of the peptide
into the bilayer. As a result, about 0.7 kcal/mol of additional free energy is released at low
pH (Figure S7). This energy could be used to move cell-impermeable cargo, such as
amanitin, across membrane and target acidic tumors. Because Trp residues have higher
affinity to the headgroups region compared to the central hydrophobic part of the bilayer,
the peptide is equilibrated in the regions of head- groups between inner and outer leaflets
of the bilayer. We and others showed that pH equilibrates fast inside a liposome40,41. Thus,
an equal amount of the peptide molecules is distributed between both leaflets of the
liposomal membrane with low pH outside and inside of it (Figure S6). However, in the
case of live cells, pH inside a cell is normal (7.2–7.4), while bulk extracellular pH is slightly
lower (6.5–6.8)42–44. However, the pH is at its lowest at the surfaces of cells9 and increases
with distance from the cellular membrane, becoming normal in the vicinity of blood
vessels45. Recently, we were able to measure in vitro and in vivo pH in the vicinity of
plasma membrane of cancer cells, the pH values drops to 6.0–6.5 at the surface of cancer
cells12. The most aggressive cancer cells are the most acidic. Thus, peptides reaching inner
leaflet of the bilayer could expose their Glu residues to the cytoplasm, where they are
expected to be de-protonated and became charged again. It would reduce the rate of the
peptide diffusion back into the membrane and should lead to the shift of the equilibrium
toward the accumulation of the peptides at inner leaflet of bilayer of the plasma membrane
of cells (Fig. 8).
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Thus, cyclic peptides could be considered as a weak acid with multiple protonatable
groups, which can diffuse across the bilayer. For weak acids, the intracellular-extracellular
distribution, Ci / Ce, should be calculated according to the following equation:

𝐶𝑖
𝐶𝑒

=

1+10𝑝𝐻𝑖−𝑝𝐾𝑎
1+10𝑝𝐻𝑒−𝑝𝐾𝑎

(1)

where pHi and pHe are the intracellular and extracellular pH values, respectively. Since the
have affinity to the membrane, we consider Ci and Ce as the concentrations of the peptide
on inner and outer leaflets, respectively. We established the pKa of membrane partition for
the asymmetric cyclic peptide, which equals to 5.7. The calculation shows that at pHe = 7.4
and pHi = 7.2 the concentration ratio at the inner and outer leaflets for asymmetric cyclic
peptides is 0.6. However, the same ratio increases to 4.5, 7.8, and 10.9 if extracellular pHe
would be 6.5, 6.2 and 6.0, respectively. We assume that the symmetrical WE peptides have
the same mechanism of action as an asymmetric peptide, however they have less favorable
localization of Trp and Glu residues, which reduces their ability to accumulate at the inner
leaflet of bilayer of cellular membranes and target acidic tumors. Leu-containing peptides
are less advantageous due to their reduced affinity to the headgroup part of the bilayer and
high affinity to the center of the membrane.
A novel class of pH-sensitive cyclic peptides containing tryptophan and glutamic
acid residues have potential applications for targeting tumors and translocation of polar
cargo molecules across cellular membrane. These peptides might have application not only
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in targeting of acidic diseased tissue, they might find very interesting applications in
cosmetics. It is well known that the natural skin surface pH is on average below 546. Thus,
topical application of short (8–10 residues long), very stable cyclic peptides might open an
opportunity to tether various cosmetic and skin care products to the skin surface.

METHODS
Materials. The materials including Fmoc-L-amino acid building blocks, preloaded amino
acids on 2-chlorotrityl resin as solid support, and 2-(1H−benzotriazol-1-yl)-1,1,3,3tetramethyluronium hexafluoro- phosphate (HBTU) used for coupling reagents were
purchased from Chem-Impex Int’l Inc., Wood Dale, IL. Piperidine and Nmethylmorpholine were purchased from Sigma-Aldrich Chemical Co. (Milwaukee, WI).
The other chemicals such as N,N-diisopropylethylamine (DIPEA), cleavage cocktail
reagents trifluoroacetic acid (TFA), 1-hydroxy-7-azabenzotriazole (HOAt), N,N′diisopropylcarbodiimide (DIC), acetic acid (AcOH), 2,2,2-trifluoroethanol (TFE), anisole,
thioanisole, ethanedithiol (EDT), and anhydrous solvents such as N,N- dimethylformamide
(DMF), dichloromethane (DCM), hexane, acetic acid (AcOH), and 2,2,2-trifluoroethanol
(TFE) were purchased from Fisher Scientific, Pittsburg, PA.
Methodology of Peptide Synthesis. In brief, the linear protected peptide was first
assembled. Direct cleavage of peptide-attached resin in the presence of AcOH/TFE/DCM
(1:2:7 v/v/v) generated the linear peptide. Cyclization in dilute condition using DIC/HOAt
in DMF/DCM solution for 12 hours, followed by the depro- tection of the side chain by
using cleavage cocktail (TFA:thioanisole:anisole:EDT (90:5:2:3 v/v/v/v) afforded the
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cyclic

peptide.

The

peptides

were

synthesized

by

employing

the

N-(9-

fluorenyl)methoxycarbonyl (Fmoc)-solid phase chemistry using PS3 automated peptide
synthesizer (Rainin Instrument Co., Inc.) at room temperature. The peptide sequence was
assembled on preloaded amino acid on 2-chlorotriyl resin using coupling, activating, and
deprotecting reagents using HBTU, N-methylmorpholine (0.4 M), and piperidine in DMF
(20% v/v), respectively. The amino acids in the peptide sequence were coupled using
coupling reagents and activating reagent in DMF for 1 hour followed by washing with
DMF 3 times. The deprotection was carried using piperidine (20%, v/v) in DMF for 2
times, 10 minute for each time, followed by washing with DMF (3 times). The appropriate
sequence of linear protected peptide was assembled using the synthesizer. N- to C-terminal
cyclization of peptide were achieved by cleavage of protected peptidyl resin by stirring the
peptidyl resin in freshly prepared cleavage cocktail of AcOH/TFE/DCM (1:2:7, v/v/v) for
1 hour at room temperature followed by washing the resin with TFE:DCM (2:8 v/v, 2
times). The collected filtrate was evaporated using a rotary evaporator followed by
azeotropic removal of acetic acid by addition of hexane and dichloromethane to afford high
viscous liquid or solid-protected linear peptide. The crude linear protected peptide was
dissolved in excess of solvents DMF:DCM (4:1 v/v) followed by the addition of HOAt/DIC
(1:1.1 equiv) for cyclization for 12–48 hours confirmed by MALDI TOF-TOF mass
spectrometry. The solvent was evaporated under high reduced pressure in a rotatory
evaporator at 40–45 °C to remove DMF. The final cleavage of side chain protection from
the peptide were carried out after confirming the peptide cyclization by MALDI mass
spectrometer data by shaking the cyclized peptide mixture in cleavage cocktail reagent R
(TFA/thioanisole/anisole/EDT (90:5:2:3 v/v/v/v, 10–15 mL) for 2–4 hours followed by
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pre- cipitation of peptide using cold ether, centrifugation at 2500 rpm and washing with
excess of cold ether at 25 °C for 5 min. The crude peptide was purified with semi
preparative reversed phase high performance liquid chro- matography (RP-HPLC) by
using Hitachi L-2455 on a C18 Phenomenex Prodigy reversed-phase column (10 μ m, 250
cm × 21.2 cm). The pure peptide was eluted at 15.0 mL/min using a gradient of binary
solvent system using water and acetonitrile with 0.1% TFA for 0–100% over 60 min. The
pure collected peptide fractions were pooled and lyophilized to provide solid powder in
purity of ≥98%. All peptides were characterized by using high resolution time of flight
AXIMA-performance MALDI TOF-TOF mass spectrometer (Shimadzu). The above
mentioned protocol was applied for the synthesis of all cyclic peptides. The concentration
of the peptides was calculated spectrophotometrically by measuring absorbance at 280 nm.
The extinction coefficients, ε280, M−1 cm−1, for the peptides are the following:
c[(WE)4WC] = 28,000; c[(WE)5WC] = 33,600; c[(WE)3WC] = 2,400; c[(LE)4WC] =
5,600; c[E4W5C] = 28,000; l(CW(EW)4) = 28,000.
Synthesis of Cyclic Peptides. The linear peptide sequence was synthesized on PS3
automated synthesizer as described above in the scale of 0.3 mmol. H-Trp(Boc)-2chlorotrityl resin (384.6 mg, 0.3 mmol, 0.78 mmol/g) was swelled in DMF, followed by
coupling and deprotection cycles to assemble respective amino acids on the pep- tidyl resin
using respective amino acids, such as Fmoc-Glu(OtBu)-OH (382.9 mg, 0.9 mmol), FmocTrp(Boc)-OH (473.9 mg, 0.9 mmol), Fmoc-Cys(Trt)-OH (527.1 mg, 0.9 mmol), and
HBTU (341 mg, 0.9 mmol) as the coupling reagent. Fmoc group of N-terminal in the
peptidyl resin was removed using deprotection cycle, and the resin was transferred to 100
mL round bottom flask. The linear protected peptide was cleaved by shaking peptidyl resin
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in cleavage cocktail AcOH/TFE/DCM (1:2:7 v/v/v, 50 mL) for 1 hour followed by washing
the resin using TFE:DCM (2:8 v/v, 10 mL, 2 times). The combined filtrate was evaporated
to dryness with the subsequently addition of hex- ane (50 mL × 3) and DCM (10 mL × 3)
to remove acetic acid, which provided solid white crude protected peptide ready for
cyclization. The cyclization was carried out by dissolving the solid peptide in anhydrous
DMF/DCM (250 mL, 4:1 v/v) under nitrogen using DIC (155.0 μL, 0.99 mmol) and HOAt
(122.5 mg, 0.9 mmol) with stirring at room temperature for 24 hours. The cyclized product
was confirmed by taking a small aliquot of the reaction mixture and cleavage with reagent
R and using MALDI. After cyclization was confirmed, the solvents were evap- orated
under high reduced pressure, and the side chain protections were removed by addition of
cleavage cock- tail of reagent R, TFA/thioanisole/anisole/EDT (15 mL, 90:5:2:3 v/v/v/v),
and shaking at room temperature for 3 hours. The peptides were precipitated, centrifuged,
and washed with cold diethyl ether to yield the crude white solid peptide. The peptides
were dissolved in H2O/CH3CN with 0.1% TFA and purified using RP HPLC. Then, the
pure fractions were collected, concentrated and lyophilized to afford pure solid white
powder of c[(WE)4WC] peptide. MALDI-TOF (m/z) [C78H83N15O18S]: calcd, 1549.6;
found, 1572.3 [M + Na ]+; c[(WE)5WC]: MALDI-TOF (m/z) [C94H100N18O22S]: calcd,
1864.7; found, 1865.4 [M + H]+; c[(WE)3WC]: MALDI-TOF (m/z) [C62H66N12O14S]:
calcd, 1234.5; found, 1234.7 [M]+; c[(LE)4WC]: MALDI-TOF (m/z) [C58H87N11O18S]:
calcd, 1257.6; found, 1258.2 [M + H]+; c[E4W5C]: MALDI-TOF (m/z) [C78H83N15O18S]:
calcd, 1549.6; found, 1549.1 [M]+. A similar procedure was used for the synthesis of
c[R4W5C] except using Fmoc-Arg(Pbf)-OH instead of Fmoc-Glu(OtBu)-OH. c[R4W5C]:
MALDI-TOF (m/z) [C82H103N27O10S]: calcd, 1657.8; found, 1658.5 [M + H]+.
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Synthesis of l(CW(EW)4). The linear peptide was assembled as described above using HTrp(Boc)- 2-chlorotrityl resin (384.6 mg, 0.3 mmol 0.78 mmol/g) in reaction vessel. The
peptide sequence was assem- bled using the appropriate amino acid building blocks FmocGlu(OtBu)-OH (382.9 mg, 0.9 mmol), Fmoc-Trp(Boc)-OH (473.9 mg, 0.9 mmol), FmocCys(Trt)-OH (527.1 mg, 0.9 mmol), and HBTU (0.9 mmol, 341 mg) as the coupling
reagent. The final N-terminal Fmoc group was deprotected. The peptide was cleaved from
the resin and side chain was deprotected by reaction of the peptidyl resin with freshly
prepared cleavage cocktail reagent R, TFA/thioanisole/anisole/EDT (15 mL, 90:5:2:3
v/v/v/v), for 3 hours at room temperature. The linear protected peptide was precipitated,
centrifuged, and purified by using RP-HPLC as mentioned above to yield l(CW(EW)4).
MALDI-TOF (m/z) [C78H85N15O19S]: calcd, 1567.6; found, 1606.1 [M + K]+.
Labeling of Peptides with Fluorescent Dyes. Peptides were conjugated with Alexa546and Fluorescein- 5-maleimide (Life Technologies) in DMF at a ratio of 1.2:1 and incubated
at room temperature for about 6 hours and then at 4 °C until the conjugation reaction was
completed. 50 mM of sodium phosphate/150 mM NaCl buffer pH 7.0 (saturated with
argon) was added to the reaction mixture (1/10 of the total volume). The reaction progress
was monitored by the reverse phase HPLC. The products were purified by the reverse phase
HPLC, lyophilized and characterized by SELDI-TOF mass spectrometry. The
concentration of the constructs was deter- mined by absorbance at 556 and 494 nm using
molar extinction coefficients of 93,000 M−1·cm−1 for Alexa546 and 68,000 M−1·cm−1
for Fluorescein-5 (FITC).
Synthesis of Peptide-Amanitin Constructs. We conjugated symmetric c[(WE)4WC] and
asymmetric c[E4W5C] peptides with alpha-amanitin (Sigma-Aldrich) via cleavable S-S
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bond. Furthermore, asymmetric c[E4W5C] peptide was labelled with amanitin via noncleavable bond. The conjugation scheme consisted of 2 steps: i) OH group of amanitin was
conjugated with NHS group of the cleavable crosslinker, SPDP, N-succinimidyl 3-(2pyridyl-dithio)-propionate

or

the

non-cleavable

crosslinker,

GMBS,

N-γ-

maleimidobutyryl-oxysuccinimide ester (both crosslinkers were from (Thermo Scientific)
in 50 mM sodium phosphate/150 mM NaCl buffer pH 8.0 at a ratio 1:20 at room
temperature for 4 hours to get SPDP-amanitin or GMBS-amanitin. The products were
purified by the reverse phase HPLC on Zorbax SB-C18 column (9.4 × 250 mm, 5-Micron).
SPDP-amanitin was eluted using a gradient: 0–25%, 40 min (water and acetonitrile with
0.05% TFA) and lyophilized. c[(WE)4WC] and c[E4W5C] peptides were incubated with
SPDP-amanitin or GMBS-amanitin in 100 mM sodium phosphate/150 mM NaCl buffer
pH 7.8 (saturated with argon) at a ratio 1:1 at room temperature for 1 hour to obtain
amanitin-SPDP-peptides or amanitin-GMBS-peptide, respectively. The products were
purified by the reverse phase HPLC on Zorbax SB-C18 column (9.4 × 250 mm, 5-Micron)
using gradient 10–55%, 40 min (water and acetonitrile with 0.05% TFA). The products
were lyophilized and characterized by SELDI-TOF mass-spectrometry. The calculated and
obtained masses for the peptides were the following: c[E4W5C]-SPDP-amanitin: SELDITOF (m/z) [C120H139N25O33S3]: calcd, 2553.9; found 2555.5 [M + H]+; c[E4W5C]-GMBSamanitin: SELDI-TOF (m/z) [C125H144N26O35S2]: calcd, 2632.9; found 2634.6 [M + H]+,
and

2657.8

[M

+

Na]+;

c[(WE)4WC]-SPDP-amanitin:

SELDI-TOF

(m/z)

[C120H139N25O33S3]: calcd, 2553.9; found 2554.5 [M + 1]+.
Liposome Preparation. Large unilamellar vesicles (LUVs) were prepared by extrusion.
POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids), or a
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mixture

of

POPC

with

0.5%

of

18:1

NBD-PE,

1,2-dioleoyl-sn-glycero-3-

phosphoethanolamine-N-7-nitro-2-1,3-benzoxadiazol-4-yl ammonium salt (Avanti Polar
Lipids) were dissolved in chloroform, desolvated on a rotary evaporator, and dried under
high vacuum for several hours. The phospholipid film was then rehydrated in 10 mM
phosphate buffer pH 8.0, vortexed until the lipid bilayer was completely dissolved, and
repeatedly (15–21 times) extruded through the membranes with 50 nm pore sizes to obtain
LUVs.
Steady-State Fluorescence and CD. Freshly prepared peptides and POPC vesicles were
mixed to have 5 μM of a peptide and 1.25 mM of lipids in the final solution. Steady-state
fluorescence measurements were carried out on a PC1 spectrofluorometer (ISS, Inc.) under
temperature control at 25 °C. Tryptophan fluorescence was excited at 280 nm (there is no
Phe or Tyr in the peptides) and recorded with the excitation and emission slits set at 1 nm.
The polarizers in the excitation and emission paths were set at the “magic” angle (54.7°
from the vertical orientation) and vertically (0°), respectively. Steady state CD
measurements were carried out in MOS 450 spectropolarimeter (Bio-Logic, Inc.) with the
same concentrations of peptide and lipids used in fluorescence measurements.
pH-Dependence. pH-dependent partitioning of the peptides into a lipid bilayer of the
membrane was investigated by the shift of the position of the fluorescence spectral
maximum for the peptides in the presence POPC liposomes induced by a drop of pH from
8 to 2.5 by the addition of HCl. The peptides were incubated overnight with 50-nm POPC
liposomes (final concentration of the peptides and POPC in solution was 5 μM and 1 mM,
respectively), and pH decrease was achieved by the addition of aliquots of 4, 2, 1 and 0.1
M HCl. pH was measured by micro-electrode probe (Thermo Electron Corporation, Orion
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Ross Micro pH electrode). Fluorescence spectra were recorded at each pH value. The
spectra were analyzed by the decomposition algorithms using on-line PFAST toolkit47
(Protein Fluorescence and Structural Toolkit: http://pfast.phys.uri.edu/) to establish the
position of the emission maximum. Finally, the positions of the fluorescence spectral
maxima (λmax) were plotted versus pH, and the Henderson–Hasselbalch equation was used
to fit the data (using Origin 8.5 software):

𝜆𝑚𝑎𝑥 = 𝜆1𝑚𝑎𝑥 +

(𝜆1𝑚𝑎𝑥 −𝜆2𝑚𝑎𝑥

(2)

1+10(𝑝𝐻−𝑝𝑘𝑎)

where λ1max and λ2max are the beginning and the end of the transition, respectively, and pKa
– is the midpoint of the transition.
Titration. Samples containing 5 μM of peptides at pH 8 and pH 3, and varying
concentrations of lipids of the 50 nm POPC liposomes were prepared. The fluorescence
spectra of peptides in all samples were measured at 280 nm excitation at 25 °C. A series of
POPC blanks with the same concentrations of lipids were measured with the same
instrument settings and were subtracted from the corresponding fluorescence spectra of
peptides in the presence of POPC. The areas under the emission spectra were calculated
and the values were normalized to the first point (the emission of the peptide in the absence
of POPC). The titration data were fitted by the peptide-membrane partition model to
calculate the mole-fraction partition coefficient, K
𝐾∙𝐶

𝑙𝑖𝑝
𝐹 = 𝐹0 + ∆𝐹 𝑊+𝐾∙𝐶

𝑙𝑖𝑝
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(3)

F0 is the fluorescence intensity at zero concentration of lipids (in our case F0 = 1); ΔF if
the fluorescence increase in the result of the titration with lipids; Clipids is the concentration
of lipids; W is the molar concentration of water (55.3 M). Nonlinear least squares curve
fitting procedure using Levenberg-Marquardt algorithm was implemented in Origin 8.5.0
SR1. The Gibbs free energy (ΔG) was calculated according to the equation:

∆𝐺 = −𝑅𝑇 ∙ ln(𝐾)

(4)

where R is the gas constant and T is the temperature in Kelvin.

Dual Quenching. POPC liposomes without and with 10% of the lipids replaced by 10doxylnonadecane (10-DN) (Avanti Polar Lipids) were prepared in 10 mM citratephosphate buffer pH 8.0. Peptides and POPC liposomes were mixed to generate final
concentrations of 7 μM peptide and 2.1 mM POPC without and with 10-DN. In some of
the samples, the pH was lowered to pH 4 by addition of aliquot of 2 M citric acid, and other
samples were kept at pH 8. Quencher, acrylamide (Sigma-Aldrich), was added to the
samples of POPC liposomes containing no 10-DN, to have final concentration of 235 mM
acrylamide. Concentration of peptides in all samples was kept constant. To observe
quenching of tryptophan fluorescence by 10-DN or acrylamide, the tryptophan
fluorescence was recorded as described above. The appropriate POPC blanks were
measured and subtracted from the measured spectra before analysis. The percentage of
quenching was calculated.
NBD-FRET. First, symmetrically NBD-labelled POPC liposomes containing 0.5% of
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NBD-PE were prepared. Next, 1.2 mL of 6 mM of symmetrically NBD-labelled POPC
liposomes were incubated with 150 μL of 1 M freshly prepared membrane-impermeable
dithionite in buffer at pH 8.0 to chemically deactivate of NDB only at the outer leaflet of
the bilayer and obtain asymmetrically NBD-labelled POPC liposomes. The decrease of
NBD fluorescence occurring in the result of quenching of NBD by dithionite was
monitored at the excitation of 463 nm and emission at 530 nm. The dithionite quenching
led to the reduction of about 60–65% of NBD fluorescence signal corresponding to the
quenching of NBD at the outer leaflet of the bilayer. Next, POPC solution was passed
through a G-10 sephadex (Sigma-Aldrich) fast spin column to remove the excess of
dithionite. Asymmetrically labelled POPC liposomes were incubated with peptides at
concentrations indicated above, and FRET from tryptophan residues to NBD at the inner
leaflet of bilayer was monitored at 280 nm excitation wavelength, and emission was
recorded from 310 to 580 nm.
Cell Lines. Human cervix adenocarcinoma (HeLa) cells were acquired from the American
Type Culture Collection. Cells were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), 10 μg/mL of ciprofloxacin in
a humidified atmosphere of 5% CO2 and 95% air at 37 °C.
Cytotoxic Assay. HeLa cells were loaded in the wells of 96-well plates (~5,000 cells per
well) and incubated overnight. Growth medium was replaced with the medium without
FBS pH 6.2 or pH 7.4 containing increasing amounts of constructs (5, 10, 20, and 40 μM).
The same volume of DMEM medium supplemented with 20% FBS, pH 7.4 was added
after 2 hours of treatment. After 48 hours of incubation a colorimetric reagent (CellTiter
96 AQueous One Solution Assay, Promega) was added for 1 hour followed by measuring
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absorbance at 490 nm to assess cell viability. All samples were prepared in triplicate.
Proliferation Assay. HeLa cells were loaded in the wells of 96-well plates (~5,000 cells
per well) and incubated overnight. Growth medium was replaced with the medium without
FBS pH 6.0 or pH 7.4 containing increasing amounts of peptide-amanitin construct (0.5,
1, 2, and 4 μM). The construct was removed from cells after 3 hours. After 48 hours of cell
incubation in standard growth medium, a colorimetric reagent (Cell Titer 96 AQueous One
Solution Assay, Promega) was added for 1 hour followed by measurements of absorbance
at 490 nm to assess cell viability. All samples were prepared in triplicate.
Fluorescent Microscopy. HeLa cells (8,000 cells per dish) were seeded in the center of a
35-mm dish with a 10-mm glass-bottom window coated with collagen (MatTek Corp).
Next day cells were incubated with 5 μM of FITC-labelled c[E4W5C] peptide for 30 min
in DMEM medium without FBS at pH 7.4 or 6.2. Cells were washed 5 times at pH 7.4 and
0.4% Trypan Blue was added for 5 min (1/10 of the total volume). Fluorescent images were
acquired with a Retiga CCD camera (Qimaging) mounted to an inverted Olympus IX71
microscope (Olympus America, Inc.).
Cellular uptake. HeLa cells (150,000 cells per sample of total volume of 500 μL) were
incubated with 5 μM of Alexa546-labelled peptide in Leibovitz’s (L15) medium at pH 6.2
and 7.4 in the presence or absence of 4% of fetal bovine serum (FBS) for 6 hours, followed
by extensive washing with L15 medium. The cellular uptake of the constructs was
measured by fluorescent signal from cells counted using cellometer (Cellometer Vision
CBA, Nexcelom). 4% of FBS was used to mimic the amount of albumin in whole blood,
which contains 45% of red blood cells, white blood cells and platelets suspended in plasma
(about 55% of volume). Plasma is composed of about 92% of water, 1% of vitamins,
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sugars, salts, minerals, hormones and 7% of vital proteins including albumin, gamma
globulins and other clotting factor. Thus, the amount of albumin in whole blood is expected
to be less than 3.6%.
Ex Vivo Fluorescence Imaging. All animal studies were conducted according to the
animal protocol AN04-12-011 approved by the Institutional Animal Care and Use
Committee at the University of Rhode Island, in compliance with the principles and
procedures outlined by NIH for the Care and Use of Animals. 4T1 breast tumors were
established by subcutaneous injection of 4T1 cells (8 × 105 cells/0.1 mL/flank) in the right
flank of adult female BALB/c mice (about 19–22 g weight) obtained from Harlan
Laboratories. When tumors reached about 6 mm in diameter single tail vein injections of
100 μl of 40 μM Alexa546-peptides were performed. Control mice bearing tumor used to
establish an auto fluorescence signal did not receive fluorescent peptides. At 4 hours postinjection euthanization and necropsy was performed followed by ex vivo imaging of tumor,
kidneys, liver, lungs and muscle. Mean fluorescence intensity of tumor and organs was
calculated using Kodak software.
Statistical analysis. Statistically significant differences were determined by two-tailed
unpaired Student’s t-test (p-level < 0.05 was taken as significant).
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FIGURES

Figure 1: Chemical structures of six cyclic and one linear peptides containing tryptophan
(Trp, W), leucine (Leu, L), glutamic acid (Glu, E), arginine (Arg, R) and cysteine (Cys, C)
residues.
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Figure 2: The changes of tryptophan fluorescence are used to follow the partition of the
peptides into POPC liposomes as a function of pH.
Fitting curves (red lines) and 95% confidence interval (blue lines) are shown.
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Figure 3: Quenching of fluorescence of peptides in the presence of POPC liposomes at pH
8 (blue lines) or at pH 3 (red lines) by acrylamide (green lines) and 10-DN (magenta lines)
are shown.
The percentage of quenching is given in Table S3.
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Figure 4: NBD fluorescence spectra of peptides in phosphate buffer at pH 8 (black lines)
and in presence of asymmetrically labelled POPC liposomes containing NBD at the inner
leaflet at pH 8 (blue lines) and at pH 3 (red lines) are shown.
The numbers indicate an increase of FRET at pH 3 compared to the peptide fluorescence
in phosphate buffer at pH 8.
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Figure 5 (a–c) Concentration- and pH-dependent inhibition of HeLa cells proliferation was
monitored at 48 hours after incubation of cells within (a) cleavable c[(WE)4WC]-S-Samanitin, (b) cleavable c[E4W5C]-S-S-amanitin and (c) non-cleavable c[E4W5C]-amanitin
constructs for 3 hours at normal (pH 7.4) and low (pH 6.0) pHs followed by constructs
removal and keeping cells in DMEM with 10% FBS at pH 7.4. (d) HeLa cells were treated
with FITC-labelled c[E4W5C] peptide conjugate (5 μM) for 30 min at pH 7.4 or 6.2,
followed by washing at pH 7.4 in both cases, addition of Trypan Blue for 5 min and live
cell imaging. (e) Cellular uptake of Alexa546-labelled c[E4W5C] peptide conjugates (5
μM) treated with HeLa cells for 6 hours in L-15 media at pH 6.2 in absence and presence
of 4% of FBS, followed by washing and counting of fluorescent signal from cells using
cellometer. Data are presented as mean ± St.D. The two-tailed unpaired Student’s t-test was
used to calculate p-levels.
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Figure 6: Ex vivo fluorescence imaging of tumor, muscle, lungs, liver and kidneys
collected at 4 hours after intravenous administration of Alexa546-peptides are shown.
Three mice per peptide were used in the study.
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Figure 7: Ex vivo fluorescence imaging of tumor, muscle, lungs, liver and kidneys
collected at various time points after intravenous administration of Alexa546
asymmetric c[E4W5C] (a) and c[R4W5C] (b) peptides; (c) Tumor/organ ratios calculated
from the obtained data. Three mice per time point, per peptide were used in the study.
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Figure 8: The cyclic peptide molecules distribution between outer and inner leaflets of the
lipid bilayer of plasma membrane.
At neutral and high pHs, Glu residues are negatively-charged (red circles). Trp residues
(green circles) interact with polar headgroups. Cys residue (yellow circle) could be directed
into bilayer or away depending on cargo hydrophobicity conjugated with Cys. The majority
of cyclic peptides could be found on the outer bilayer of plasma membrane of normal cells
compared to the inner bilayer due to the small pH gradient (pHe = 7.4 and pHi = 7.2). A
drop of a pH leads to the protonation of Glu residues (blue circles), which enhances
peptides hydrophobicity and induces partition into the bilayer.
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Abstract
The pH (low) insertion peptide (pHLIP) is a family of peptides that are able to insert into a
lipid bilayer at acidic pH. The molecular mechanism of pHLIPs insertion, folding and
stability in the membrane at low pH is based on multiple protonation events, which are
challenging to study at molecular level. More specifically, the relation between the
experimental pK of insertion (pKexp) of pHLIPs and the pKa of the key residues is yet to be
clarified. We carried out a computational study, complemented with new experimental data,
and established the influence of (de)protonation of key titrable residues on the stability of
the peptide membrane-inserted state. Constant-pH molecular dynamics simulations were
employed to calculate the pKa values of these residues along the membrane normal. In the
wt-pHLIP, we identified Asp14 as the key residue for the stability of the membrane-inserted
state, and its pKa value is strongly correlated with the experimental pKexp measured in
thermodynamics studies. Also, in order to narrow down the pH range at which pHLIP is
stable in the membrane, we designed a new pHLIP variant, L16H, where Leu in the 16th
position was replaced by a titrable His residue. Our results showed that the L16H variant
undergoes two transitions. The calculated pKa and experimentally observed pKexp values are
in good agreement. Two distinct pKexp values delimit a pH range where the L16H peptide
is stably inserted in the membrane while, outside this range, the membrane-inserted state
is destabilized and the peptide exits from the bilayer. pHLIP peptides have been
successfully used to target cancer cells for the delivery of diagnostics and therapeutic
agents to acidic tumors. The fine tuning of the stability of pHLIP inserted state and its
restriction to a narrow well-defined pH range might allow the design of new pHLIPs, able
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to discriminate between tissues with different extracellular pH values.

INTRODUCTION
The pH (low) insertion peptides (pHLIP) is a family of peptides that insert into
lipid bilayers at low pH.1–8 The original version of this peptide was derived from a
transmembrane C helix of bacteriorhodopsin.1 Biophysical studies revealed three
major states of pHLIPs (see Figure 1 in Ref. 9): (State I) when the peptide is in solution
and does not adopt a defined structure; (State II) in the presence of a membrane at
neutral or high pH the peptide is mostly unstructured yet adsorbed to the bilayer surface
(pHLIPs with different sequences adopt different configurations in this state10,11);
finally (State III), by lowering pH, the key residues protonate, leading to an increase
of the peptide hydrophobicity and insertion across the membrane to form a stable
transmembrane (TM) α-helix.3 This behaviour from pHLIP peptides is significantly
different from other typical transmembrane peptides, such as the WALP/KALP
peptide family.12–16 In this case, the high membrane affinities are pH-independent
and lead to inserted transmembrane helical structures, even when ionized residues are
introduced in the middle of the WALP sequence.16,17
pHLIP sequences share common features: a TM region, with hydrophobic
residues and one or more acids (Asp or Glu), and N- and C-terminus flanking
sequences. Both flanking sequences have several charged residues, which are essential
for peptide solubility. In most pHLIPs, C-terminus flanking sequences are transient
membrane inserting segments18), which contain a variable number of anionic groups,
affecting the rate of pHLIP insertion withdrawal from the bilayer.5 The TM sequence
(WARYA14DWLFTTPLLLL25DLALLV) of wild- type (wt) pHLIP contains many
hydrophobic residues (including two Trp residues, which are used to monitor the
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propagation of the peptide into the lipid bilayer) and two Asp residues at positions 14
and 25. These titrable residues play an essential role in both the pH-dependent insertion
of pHLIP into the lipid bilayer and the stability of the membrane-inserted state, since
they must be protonated (at least partially) for insertion process to occur.19
Thermodynamics studies of Trp fluorescence changes in pHLIP with pH on
liposomes allow to investigate the stability of the membrane-inserted state at different
pH values, which is typically presented by a pK of the peptide insertion (pKins – onward
referred as pKexp). This pK value is expected to be related with the pKa of one or both
Asp residues at the mem- brane/water interface. In fact, the pKexp of the wt-pHLIP is
6.0,20 which is the expected value for Asp at the interface.21 Moreover, pHLIP peptides
with single mutations D14E or D25E (Asp− >Glu) show an increase in the pKexp of ∼
0.5 pK units,20 which is approximately the difference in the pKa values between Asp
and Glu in solution. This suggests that the pKa values of these acids are strongly related
with pKexp. The effect of shifting Asp14 to the 13th or 15th positions which, in
principle, changes the solvent exposure of this residue, has also been studied.22 These
results, where the pKexp decrease is concomitant with an increase of solvent exposure
(13th position) and vice versa,22 suggest a crucial role of Asp14 in the stability of the
membrane-inserted state.
A typical pHLIP variant has a single value of pKexp: a pH below which more
than 50% of the peptide population is inserted in the bilayer. Since acidosis is a
universal marker for tumor identification, the pH-sensitive interaction of pHLIPs with
the cell membrane renders it a good transport system for tumor targeting, delivering
drugs and imaging agents to cancer cells. pHLIP can target and accumulate in tissues
with the extracellular pH below pKexp, usually cancer cells in tumors, but also naturally
acidic organs, such as kidneys and stomach (in the case of oral administration).20,23,24
It would be advantageous to control the stability of pHLIP’s inserted state and restrict
it to a narrow well-defined pH range. Cationic residues, when protonated (charged),
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have been shown to hinder pHLIP membrane insertion.23 A histidine residue, when
inserted in a lipid bilayer, has its pKa value shifted below the pKa of aspartic acid,21
leading to a protonation event (generation of a positive charge), which could
destabilize the membrane-inserted state and induce the peptide withdrawal from the
membrane. In theory, it is required a large enough difference between the His and Asp
pKa values to generate a significant population of the inserted peptide (where His and
Asp are in their neutral forms), but narrow enough to allow the peptide to discriminate
between organs/tumors with slightly different acidities.
The investigation of the protonation states of the titrable residues in pHLIPs is
an essential step to understand the molecular mechanism of pHLIP action and might
open an opportunity to design new peptide variants with desirable targeting properties.
Computational approaches are well suited to address this challenge. In particular,
molecular dynamics (MD) simulations have been used to investigate the membrane
insertion mechanism25,26 and the stability of pHLIP.27 However, in classical MD
simulations all protonation states are fixed, which means that pH is not explicitly
modeled. Constant-pH molecular dynamics (CpHMD) methods21,28–51 have been
developed over the years to allow the inclusion of pH effects in MD simulations. In
the stochastic titration method, the Poisson–Boltzmann estimated energies are used in
Monte-Carlo calculations to obtain protonation states that are representative of the
system conformation/configuration. The use of continuum electrostatics to obtain the
free energies of changing protonation states has been successfully adopted by many
methods,21,30–45 while offering the important advantage of computational speed. We
have extended the stochastic titration method30,34 to include lipid bilayers (CpHMDL)43,44 in order to study the protonation profiles of peptides and proteins interacting
with lipid bilayers.21 This methodology was recently used to calculate the pKa values
of individual titrable amino acids when inserting in a lipid bilayer and showed that,
despite sampling limitations, it was possible to estimate pKa values at deep inserted
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positions, right before losing contact with bulk water, hence with the proton buffer.21
Here, we used our recently developed CpHMD-L method to study the
protonation profile of all titrable amino acids in pHLIP when inserted in a lipid bilayer
(State III). These simulations were performed to identify the key residues determining
the stability of pHLIP in the membrane, which is reflected by the observed
experimental pKexp. We also proposed a new pHLIP sequence with a histidine located
near the key Asp14 (L16H pHLIP variant). Computer simulations predicted a second
protonation event at lower pH values, that experimental results confirmed to be also
related with a peptide withdrawal from the membrane.

METHODS
2.1 System setup and CpHMD simulations
In this work, we focused our efforts on the wt sequence of pHLIP24 and L16H variant
(see Table 1). In the case of L16H variant, we replaced the Leu residue at the 16th
position with Table 1: pHLIP sequences used in this work. Asp14 and His16 positions
are underlined.

Variant
Sequence
wt
ACEQNPIYWARYA14DWLFTTPLLLL25DLALLVDADEGT
L16H ACEQNPIYWARYA14DWHFTTPLLLL25DLALLVDADEGT

a His since, being two positions below Asp14 in a α-helical structure, the two residues
should point to opposite directions. The rationale is based on the assumption that these
residues do not interact strongly, thus, they should have their pKa values only weakly
correlated wt and L16H pHLIP sequences were simulated using the stochastic titration
CpHMD- L method.21,30,34,43,44 The peptides were built inserted in a bilayer of 256 2oleoyl-1-palmitoyl- sn-glycero-3-phosphocholine (POPC) lipid molecules and placed
with Asp14 and Asp25, in their protonated (neutral) forms, equidistant to the
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membrane center. This unbiased configuration was chosen to avoid favouring the
solvent exposure of one acidic residue over the other. The protonation states of Asp,
Glu, His, Cys, C-ter and N-ter were allowed to titrate in the pH range of 4.0 to 7.0,
with a 1.0 pH step. Each CpHMD cycle was 20 ps long (τprt) and each solvent
relaxation step was 0.2 ps long (τrlx). At each pH value, three replicates were
performed for 100 ns. Within this short time scale, the peptides are expected to remain
inserted in the membrane which allows us to characterize the pH effects on the
membrane- inserted state of pHLIP (State III). The first 20 ns were disregarded in the
analyses to allow for system equilibration.
2.2 Molecular dynamics settings
All molecular dynamics simulations were performed with the GROMOS 54A7 force
field52 using a modified version34 of GROMACS 4.0.7.53 A twin-range scheme was
used with short- and long-range cutoffs of 8 and 14 Å, respectively, with neighbor lists
between the two cutoff values being updated every 5 steps. Long-range electrostatic
interactions were treated with the generalized reaction field (RF) method.54 Although
the RF method is not optimal to capture the long range electrostatics of membrane
systems, due to its anisotropic nature, there are several advantages in its use within the
CpHMD framework, namely the high computation speed and its consistency with the
recent GROMOS force fields (including lipid parameters),55 where all parametrization
and validation were performed with this method. Recently, it has been shown that the
system net charge can introduce systematic errors in pKa values obtained with a λdynamics based CpHMD method.56 However, with our CpHMD method, which uses
GRF and an implicit ionic strength in the protonation calculations (see below), we have
not observed such effects.

34,45

The RF dielectric constant used was 5 4 5 7 a n d an

ionic strength of 0.1 M was also employed. The lipid and protein bond lengths were
constrained using the P-LINCS algorithm, 58 while the SETTLE algorithm59 was used
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for water molecules (simple point charge, SPC60). Newton equations of motion were
integrated using a time step of 2 fs keeping constant the number of molecules, the
pressure, and the
temperature (NPT ensemble). The temperature of the systems was separately coupled
to

a v-rescale61 temperature bath at 310 K and relaxation times of 0.1 ps. A semi-

isotropic Parrinello-Rahman pressure coupling62 was used at 1 bar with a relaxation
time of 5 ps and
a compressibility of 4.5 × 10−5 bar−1.
2.3 Poisson-Boltzmann/Monte-Carlo calculations
The Poisson–Boltzmann (PB) calculations were performed using the program DelPhi
V5.1, 63 using partial charges from the GROMOS 54A7 and radii obtained from the
Lennard-Jones parameters of this force field. These calculations were performed on
the fully atomistic pHLIP/POPC system. The molecular surface of the solute (here the
solute can be seen as the membrane + peptide supramolecular complex) was defined
using a probe of radius 1.4 Å, the ion exclusion layer was 2.0 Å, and the ionic strength
was 0.1 M. A dielectric constant of 2 was used for the solute and 80 for the solvent. A
twostep focusing procedure was used with grid spacing of approximately 1 and 0.25
Å in the large and small grids, respectively (corresponding to 91 grid points). In the
coarse grid, relaxation parameters of 0.20 and 0.75 were used in the linear and
nonlinear iterations processes and periodic boundary conditions were applied in the x
and y directions. The background interactions were calculated up to 25 Å and the
convergence threshold for the electrostatic potential was set to 0.01.
The PB-derived free energy terms were then used to sample protonation states within
a Monte Carlo (MC) scheme performed using the PETIT program. 64 Proton
tautomerism was taken into account in all titrable groups. ×105 MC cycles were
performed for each conformation where a cycle corresponds to a trial change of each
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individual site.
2.4 pK a calculation along the membrane normal
To calculate the residues pKa values along the membrane normal, we split our
conformations according to their relative depth to the average position of membrane
“P” atoms within a 6 Å radius from pHLIP. This method describes better the local
deformations induced by the peptide, since it only uses neighboring “P” atoms to
obtain the reference average position.
After sorting the conformations in 1 Å insertion slices, we separate them by
protonation states of the group of interest. Here, we apply a minimum criteria of 50
frames in at least 2 pH values in order to be able to calculate the pKa values and estimate
their standard errors. The protonation states in each slice are used in a Hill fitting
procedure to obtain the respective pKa value.
Assuming that a peptide stability in the membrane is regulated by the
protonation of a single titrable residue, then the most inserted pKa value of this residue
can be regarded as our “in silico” estimation of the experimentally measured
thermodynamic parameter, pKexp. The rationale is that, upon membrane insertion, this
pKmemb value, at the last moment while the group is still in contact with solvent and
senses the pH value, will define the peptide stability in the membrane-inserted state.

2.4 Analyses and error calculations
The thickness of membrane bilayers is often calculated as the distance between the
average Z coordinate of the “P” atoms for each monolayer. However, the presence of
a peptide may induce local membrane deformations, which will affect these
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calculations. To circumvent these issues and to quantify membrane perturbations, we
developed a method that calculates monolayer thickness values, for different annulus
regions in the xy plane moving radially away from the peptide. First, we define an
unaffected region, loosely called “bulk”, which (in our simulations) corresponds to
all “P” atoms beyond a 15 Å radius from pHLIP. The membrane center is then
calculated using only these bulk phosphate atoms as reference. The membrane center
allows the splitting of the peptide atoms between the two monolayers, which can now
be used in two separate thickness calculations. Moving a sliding annulus (by
increasingly changing its radii) away from the peptide in the xy plane (2 dimensions),
we calculate the distance between the average “P” atoms (contained in the annulus) Z
position and the membrane center. This procedure is applied to all snapshots of our
simulations and, at longer radii, both monolayer thickness values should converge to
a “bulk” value, i.e. half the thickness value for pure POPC.
All error values shown in the pKa profile plots were obtained using a modified jackknife
resampling method. We generated 5 sub-set combinations of our total sampling by
using only 4 out of 5 replicates (1234, 1235, 1245, 1345, and 2345). We used these
combinations for the slicing and Hill fitting procedure. The final standard errors were
calculated using the generalized formula:
1
𝑥 − 𝑥𝑖 2
𝑆𝐸 = { ∑ (
) }
2
𝑛−1

1⁄
2

In the equation, n is the number of simulation replicates, x̄ is the predicted pKa value
and xi is the pKa value obtained in each i combination of replicates. We also apply
the previous criteria to the pKa values calculation, namely, each i sub-set requires
at least 50 frames for each protonation state and a minimum of two different pH
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values. Note that this standard error calculation procedure introduces a new
restriction criterion to the final pKa profile plots, where all protonation/insertion
values need to be originated from more than
one replicate. Finally, all error values above 2 pK units were excluded.
2.6 Synthesis of pHLIP
The L16H pHLIP variant was produced by solid-phase synthesis and purified by CS
BioCo., and was characterized by reversed-phase high performance liquid
chromatography (RT- HPLC) using Zorbax SB-C18 and Zorbax SB-C8, 4.6 × 250 mm
5µm columns (Agilent Technologies). Peptide solution concentrations were determined
using absorbance at 280 nm, where c280 = 13940 M−1 cm−1.
2.7 Liposome preparation
Small unilamellar vesicles were used as model membranes and were prepared via thin film
formation, rehydration, and extrusion. A thin lipid film was prepared by dissolving 1palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC; Avanti Polar Lipids) in
chloroform at a concentration of 33 mg mL−1, then desolvated using rotary evaporation
and placed under vacuum for 2 hours. The resulting thin POPC film was rehydrated using
2 mM citrate-phosphate buffer at pH 8. Finally, the liposome solution was vortexed and
extruded 21 times through a membrane with a pore size of 50 nm.
2.8 pH dependence measurements
The pH dependence measurements were carried out by monitoring the shift of the
position of maximum of peptide fluorescence as a characteristic of changes of the
peptide environment by varying pH. Peptide fluorescence spectra were measured using
a PC1 spectrofluorometer (ISS) with temperature control set to 25.0 ◦C. Tryptophan
residues were excited using an excitation wavelength of 295 nm. Both excitation and
emission slits were set to 4 nm widths; excitation and emission polarizers were set to
54.7◦ (magic angle) and 0.0◦, respectively. Samples were prepared 24 hours prior to
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running experiments to allow for equilibration in State II.
The pH of solutions containing 7 µM peptide and 1.4 mM POPC was lowered
using citric acid and measured using an Orion PerHecT ROSS Combination pH Micro
Electrode and an Orion Dual Star pH and ISE Benchtop Meter (Thermo Fisher
Scientific) before and after spectrum measurement to ensure equilibration. At each pH,
the tryptophan fluorescence spectrum was recorded, and the spectra were analyzed
using the Protein Fluorescence and Structural Toolkit (PFAST) to determine the
positions of spectral maxima.18 The obtained
positions of spectral maxima were plotted as a function of pH. The pH-dependence
curve was fit using Levenberg Marquardt iteration algorithm of the bi-dose response
module in Origin 2017 to determine parameters of cooperativity and mid-point of the
transitions.

2.9 Oriented circular dichroism measurements

Oriented circular dichroism (OCD) measurements were performed on an MOS-450
spectrometer (Bio-Logic Science Instruments) in the range of 190 to 260 nm with a
step size of 1 nm, and with temperature control set to 25.0 ◦C. OCD was conducted
using supported planar POPC bilayers prepared using a Langmuir-Blodgett system
(KSV Nima). Fourteen quartz slides with 0.2 mm spacers were used; after sonicating
the slides in 5% cuvette cleaner (Con- trad 70; Decon Labs) in deionized water (≥ 18.2
MΩ cm at 25 ◦C; Milli-Q Type 1 Ultrapure Water System, EMD Millipore) for fifteen
minutes, then rinsing with deionized water, the slides were immersed and sonicated
for ten minutes in 2-propanol, sonicated again for ten minutes in acetone, sonicated
once more in 2-propanol for ten minutes, and rinsed carefully with deionized water.
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Lastly, the slides were immersed in a 3:1 solution of sulfuric acid

to hydrogen

peroxide for five minutes and rinsed thoroughly deionized water. The slides were
stored in deionized water until they were used. POPC bilayers were deposited on the
fourteen slides using a Langmuir-Blodgett minitrough: a 2.5 mg mL−1 solution of
POPC in chloroform was spread on the subphase (deionized water) and fifteen minutes
was allotted for the evaporation of the chloroform, after which the POPC monolayer
was compressed to 32 mN m−1. A lipid monolayer was deposited on the slides by
drawing them from the sub- phase, after which a solution of 10 µM peptide and 500
µM of 50 nm POPC liposomes at pH 4 was added to the slides, producing supported
bilayer by fusion between the monolayer on the slides and the peptide-laden lipid
vesicles. After incubation for six hours at 100% humid- ity, the slides were rinsed with
buffer solution to remove residual liposomes, and the spaces between the cuvettes were
filled with buffer of appropriate pH. Measurements were taken at three points during
the experiment: directly after the addition of the peptide/lipid solution (0 h), after the
slides were rinsed to remove excess liposomes after the six-hour incubation time (6
h), and after an additional twelve-hour incubation time and rinse with buffer (18 h);
these measurements were recorded on the MOS-450 spectrometer with sampling times
of 1 second at each wavelength.

3 RESULTS AND DISCUSSION
3.1 Molecular details of membrane inserted pHLIP

The main goal of our work is to elucidate the role of titrable residues in the stability of
wt-pHLIP membrane-inserted state (State III). Our calculations should correlate with
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the equilibrium biophysical studies on liposomes, where pH outside and inside of a
liposome equilibrates quickly and is considered to be the same at both sides of a lipid
bilayer. 65 We carried out simulations, at different pH values (4.0–7.0), with the peptide
inserted in a POPC lipid bilayer. Within the time scale of our simulations (100 ns),
the peptide is expected to remain stable in the membrane-inserted state (the withdrawal
process occurs in a much larger time scale65), which allow us to characterize the effect
of pH on the membrane-inserted state. There is a multitude of experimental data
regarding the characterization of pHLIP in- serted in lipid bilayers.1–8,65 In particular,
the original transmembrane region (residues 9– 3066 ) has often been assumed to be
conserved with Asp14 and Asp25 inserted in the lipid bilayer. Although, the helical
content is conserved in the membrane-inserted state at all sim- ulated pH values (Figure
S1 in Supporting Information), the overall preferred position of the peptide is
significantly shifted towards the N-terminus monolayer (Figure 1 and Figure S2). At
all pH values, the peptide bends at the membrane/water interface, consistently losing
helical content around residues 15–18. Interestingly, the proline residue at the 20th
position is not directly involved in this loss of secondary structure. The presence of
Arg11 in the N-terminus domain, close to the interface, and the presence of two
segments of hydrophobic residues, 21-24 and 26-30, seem to be the main factors
determining both the position and orientation of wt-pHLIP in the lipid bilayer. At pH
6.0, which is the experimentally observed pKexp, Asp25 is preferably located at the
bilayer center, thus not exchanging protons with water. Concomitantly, Asp14 is only
partially inserted in the membrane, singling it out as the key proton active residue.
Interestingly, the peptide N-terminus is interchanging between the water phase and the
water/membrane interface, suggesting that residues 1–13 are either solvated or
adsorbed to the membrane. Varying pH leads to slightly different preferred positions
for the transmembrane region of pHLIP, where the ionization of Asp14 seems to be
the driving factor for the destabilization of the membrane-inserted state. Nevertheless,
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even at lower pH values, Asp14 is always able to reach water accessible regions and
sense the pH value. At the C-terminus, we observe that the four acidic groups (Asp31,
Asp33, Glu34, and C-ter) are also titrating and their preferred positions relative to the
membrane center seem to be a consequence of their topological order and ionization
states. At high pH values, when these residues are mostly ionized, they are not deeply
inserted as Figure S2 suggests, but rather induce a significant local deformation on the
closer monolayer. In fact, the mono- layer thickness profiles around pHLIP show a
clear local depression in the C-terminus side (Figure 2). A small bilayer deformation
(¡10 %) occurs at pH < 7.0, however, a larger effect is observed at pH 7.0 (∼20 % –
Figure S3 in Supporting Information), since, at this pH value, the more stable
thermodynamic state is not the fully inserted (State III) but rather

the membrane-

adsorbed (State II). In both cases, the observed deformations are only local being
completely dissipated at ∼30 Å radially away from the peptide. At the N-terminus
side, there is only a small membrane perturbation almost within the error bars. Also,
beyond

∼15 Å from the peptide, both monolayers thicknesses reach a plateau and the sum of
their values correspond roughly to the experimental POPC thickness (36.5 Å). 67
3.2 pKa profile of Asp14
We calculated the pKa values of Asp14 using average protonation values obtained
from the constant-pH molecular dynamics simulations (CpHMD-L). This method
allows for the titrable residues to update their protonation states depending on the
pH and their microenvironment. Hence, it is possible to measure the proton affinity of
a given group along the membrane normal. Indeed, we have previously observed that
aspartic acid, in the middle of a capped alanine pentapeptide (AADAA), has its pKa
value shifted when inserting in a lipid bilayer, favoring its neutral form.21 The pKa
values, varying with the level of residue insertion into the membrane, can be called
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pKa profiles. A key feature of this method is a good estimation of the depth of insertion
of a particular residue, which correlates with its solvent exposure, taking into
consideration the membrane local deformation. In a pKa profile, the value calculated
at the deepest membrane-inserted location of a residue, the pKa value at the limit of our
sampling, could be considered as an estimation of the pKmemb. It should correspond to
a region of scarce solvent exposure, when the residue does not exchange protons with
water anymore, and it is no longer able to sense pH. If we know which residue is
responsible for the stability of the peptide membrane-inserted state, then its pKmemb
value is our estimation of the experimental pKexp. The pKa profile of Asp14 shows
significant shift along the membrane normal, reaching a pK memb value of 6.0±0.1,
at the deepest membrane inserted position (Figure 3A), which is in excellent
agreement with the experimentally observed pK exp value (6.024).
The C-terminus region of pHLIP has five carboxylic acids, including Asp25.
In the membrane-inserted configuration, Asp31, Asp33, Glu34 and C-ter are accessing
the solvent on the other side of the bilayer, opposite to Asp14. Therefore, in this
configuration, their pKa profiles are only related to the exit pathway insertion process
of pHLIP, the protonation order of these acidic residues, is most likely related to their
topological position in the peptide sequence (Figure 1). Furthermore, their pKa values
have contributions from the desolvation effects21 and the electrostatic repulsion
between the negatively charged residues. Hence, the observed trend in the pKa profiles
is in agreement with the expected for an anionic group (Figure 3B). The protonation
(charge neutralization) of each residue, reduces the local negative potential, decreasing
the pKa shift of the remaining residues when they reach similar (despite its lack of
sampling) because, at this point, all other carboxylic groups are ionized. On the
contrary, C-terminus exhibits a small pKa shift, since it is measured in the absence of
other negative charges. Along these lines, Asp25 would show an even higher pKmemb
value, but not enough (de)protonation events were observed in our simulations,
precluding an accurate pKa calculation.
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pHLIP is in equilibrium between the membrane membrane-inserted states and
the experimental pKexp value is an average of these populations ratio. According to
our results, the occurrence of the membrane-inserted state requires complete
protonation of both Asp25 and Asp14, even though the stability of this state is
regulated only by the (de)protonation of Asp14, which is able to exchange protons with
water. The double pro- tonation is in agreement with isothermal calorimetry (ITC)
data, which estimates that 1.8 protons are required for the insertion process.19 The
four carboxylic acids at the C-terminus domain are at the water/membrane interface
in both end states, hence, their pKa values should not have a direct effect on the
equilibrium populations. However, the membrane crossing energetic barrier for a
charged group is usually unsurmountable.68,69 Therefore, in the kinetic process of the
peptide insertion (or exit) into (from) the membrane, all acidic residues in the Cterminus region would need to, at least transiently, protonate. To obtain a fully neutral
C-terminus domain, the acidic groups will likely become neutral sequentially,
following their topological order. Hence, these protonations can be slow, depending
on the number of anionic residues and their pKmemb values. This is in agreement with
the experi- mentally observed slow kinetics for wt-pHLIP, when compared with other
variants with fewer acidic residues in the aforementioned region.24

3.3 The L16H variant shows two pKexp values

The ionization of residues in pHLIP TM region induces a transition between State
III and II. In the wt-pHLIP variant, Asp14 preferentially ionizes at pH values larger
than 6.0, which leads to the destabilization of the membrane-inserted state and
peptide exit from the
. However, below pH 6.0 the peptide membrane-inserted state is well stabilized. By
introducing a cationic residue (such as histidine) we observe the opposite effect, i.e.
the peptide withdrawal from the membrane now occurs at lower pH values when the
residue is ionized.70 Hence, with a combination of these two strategies, we can design
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a peptide with
two transitions, each having its own pKexp value. In this case, provided that the
pKmemb
of the cationic group is lower than that of the anionic, the peptide will be stabilized in
its membrane-inserted state in the pH range within the two pKmemb values (Figure 4).
To test this hypothesis, we designed the L16H pHLIP variant, where the cationic
residue (His16) is deeply inserted in the membrane and facing an opposite direction
from Asp14. We have performed CpHMD simulations with this variant and calculated
the corresponding pKa val- ues (Figure 5). The obtained profiles are similar to the
observed for pentapeptides inserting into a lipid bilayer.21 The pKa value of His16
(Asp14) decreases (increases) with insertion into the membrane, since the membrane
stabilizes their neutral forms. Although the profile of Asp14 is similar to wt-pHLIP,
we observe a pKa increase in the membrane-inserted state. This suggests that the
histidine residue slightly alters Asp14 microenvironment upon insertion (even though
the conformational properties are not significantly altered - Figure S5 and S6 in
Supporting Information). The two pKa profiles show that the L16H peptide has two
pKmemb values (6.8 ± 0.2 for Asp14 and 4.7 ± 0.3 - or ∼3.1 without error bars - for
His16), thus the peptide is expected to be stabilized in the membrane-inserted state
only within the 3.1–6.8 pH range.
The L16H pHLIP variant was synthesized and its interaction with POPC
liposomes was studied employing spectroscopic techniques. The pH-dependence of
L16H pHLIP variant was observed by measuring the shift in the peptide fluorescence
spectra maximum between pH 1.5 and 8.5 (Figure 6A). The position of the maximum
of the emission spectra mainly reflects the solvent exposure of the tryptophan residues,
hence, providing information on the degree of the membrane penetration. The data
were fitted assuming two transitions and confirm the existence of two pKexp in L16H
pHLIP variant (5.9 and 3.3), which can be attributed to the pKmemb values of Asp14
and His16, respectively. To identify conformational states of L16H pHLIP at pH 2, 4
and 8 we measured OCD spectra (Figure 6B). At pH 8 no helical structure was
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observed, while at pH 4 the transmembrane orientation of helix was confirmed. When
pH was lowered to 2, the peptide helical content is still preserved. However, contrarily
to the observed at pH 4, a surface helical orientation is predominant. Overall, the
obtained results support the two-pKmemb insertion mechanism (Figure 4). Below the
lowest pKexp, the His residue in the TM region becomes positively charged, while at a
pH value above the highest pKexp, the Asp residue becomes negatively charged. In both
cases, it leads to the destabilization of the peptide membrane-inserted state and peptide
exit from the bilayer. This inserted state is only stabilized in the pH range between
the two pKexp values.
Despite on the fact that the membrane-inserted pH range is too wide to be useful
for
practical applications, the obtained results should be regarded as a proof-of-concept.
Hence, they can prompt the design of new pHLIP sequences, with different cationic
residues, that might narrow down the pKexp range to ∼1 pH unit, so pHLIP might be
able to discriminate between different cells in an organism.
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CONCLUSIONS

In this work, we studied the protonation profile of all titrable amino acids in pHLIP
when inserted in a lipid bilayer, and identified Asp14 as the key residue to act as a
sensor of

the extracellular pH in the membrane-inserted state. The peptide adopts a

preferential position in the membrane such that Asp25 remains mainly at the bilayer
center, away from water and unable to sense the pH value, i.e. it is not able to
exchange protons with the solvent. The pKmemb value calculated for Asp14 in wtpHLIP is in excellent agreement with the experimentally measured pKexp.

Our

simulations also helped to understand the role of the acidic residues at the C-terminus
flanking sequence. These residues need to be fully protonated to allow the transition
of pHLIP from the membrane-adsorbed (State II)

to the membrane-inserted (State

III) conformation. Consequently, the number of anionic groups can have a direct
influence on the kinetics of the peptide insertion process, as already observed
experimentally.24,65
The information obtained at the molecular level helped to understand the peptide
stability in the membrane and will also give important hints to devise new pHLIP variants
with specific features. An example is L16H pHLIP variant, with a histidine residue located
in the TM region, near Asp14. Our simulations predicted that this mutation adds a second
proto- nation event, at lower pH values, leading to the peptide withdrawal from the
membrane. The simulations were validated by spectroscopic data indicating the presence
of two transitions in L16H pHLIP variant. Although this proof-of-concept mutation seems
to generate a too large range between the two pKexp values, it opens an opportunity for the
design of new variants to achieve fine tuning of pH insertion range, hence increasing the
potential medical significance of pHLIP technology.
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In the future, we also plan to use new enhanced sampling strategies coupled with
CpHMD- L simulations in order to improve the accuracy of these pKa calculations.
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(45) Reis, P. B.; Vila-Viçosa, D.; Campos, S. R.; Baptista, A. M.; Machuqueiro, M.
Role of Counterions in Constant-pH Molecular Dynamics Simulations of
PAMAM Dendrimers. ACS Omega 2018, 3, 2001–2009.
(46) Wallace, J. A.; Shen, J. K. Charge-leveling and proper treatment of long-range
elec- trostatics in all-atom molecular dynamics at constant pH. J. Chem. Phys.
2012, 137,184105
(47) Bennett, W. F. D.; Chen, A. W.; Donnini, S.; Groenhof, G.; Tieleman, D. P.
Constant pH simulations with the coarse-grained MARTINI model - Application
to oleic acid aggregates. Can. J. Chemistry 2013, 91, 839–846.
(48) Chen, W.; Wallace, J. A.; Yue, Z.; Shen, J. K. Introducing titratable water to allatom molecular dynamics at constant pH. Biophys. J. 2013, 105, L15–L17.
(49) Goh, G. B.; Hulbert, B. S.; Zhou, H.; Brooks III, C. L. Constant pH molecular
dynamics of proteins in explicit solvent with proton tautomerism. Proteins
Struct. Funct. Bioinf. 2014, 82, 1319–1331.
(50) Stern, H. A. Molecular simulation with variable protonation states at constant
pH. J. Chem. Phys. 2007, 126, 164112.
(51) Radak, B. K.; Chipot, C.; Suh, D.; Jo, S.; Jiang, W.; Phillips, J. C.; Schulten, K.;
Roux,

B.

Constant-pH

Molecular

Dynamics

Simulations

for

Large

Biomolecular Sys- tems. J. Chem. Theory Comput. 2017, 13, 5933–5934.

65

(52) Schmid, N.; Eichenberger, A. P.; Choutko, A.; Riniker, S.; Winger, M.; Mark,
A. E.; Van Gunsteren, W. F. Definition and testing of the GROMOS force-field
versions 54A7 and 54B7. Eur. Biophys. J. 2011, 40, 843–856.
(53) Hess, B.; Kutzner, C.; van der Spoel, D.; Lindahl, E. GROMACS 4: Algorithms
for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J.
Chem. Theory Comput. 2008, 4, 435–447.
(54) Tironi, I. G.; Sperb, R.; Smith, P. E.; van Gunsteren, W. F. A generalized
reaction field method for molecular dynamics simulations. J. Chem. Phys. 1995,
102, 5451–5459.
(55) Poger, D.; Mark, A. E. On the Validation of Molecular Dynamics Simulations
of Sat- urated and cis-Monounsaturated Phosphatidylcholine Lipid Bilayers: A
Comparison with Experiment. J. Chem. Theory Comput. 2010, 6, 325–336
(56) Chen, W.; Shen, J. K. Effects of system net charge and electrostatic truncation
on all-atom constant pH molecular dynamics. J. Comput. Chem. 2014, 35,
1986–1996.
(57) Smith, P. E.; van Gunsteren, W. F. Consistent dielectric properties of the simple
point charge and extended point charge water models at 277 and 300 K. J. Chem.
Phys. 1994, 100, 3169–3174.
(58) Hess, B. P-LINCS: A Parallel Linear Constraint Solver for Molecular
Simulation. J. Chem. Theory Comput. 2008, 4, 116–122.
(59) Miyamoto, S.; Kollman, P. A. SETTLE: An analytical version of the SHAKE
and RATTLE algorithm for rigid water models. J. Comput. Chem. 1992, 13,
952–962.
(60) Hermans, J.; Berendsen, H. J. C.; van Gunsteren, W. F.; Postma, J. P. M. A

66

Consistent Empirical Potential for Water-Protein Interactions. Biopolymers
1984, 23, 1513–1518.
(61) Bussi, G.; Donadio, D.; Parrinello, M. Canonical sampling through velocity
rescaling.
J. Chem. Phys. 2007, 126, 014101.
(62) Parrinello, M.; Rahman, A. Polymorphic transitions in single crystals: A new
molecular dynamics method. J. Appl. Phys. 1981, 52, 7182–7190.
(63) Rocchia, W.; Sridharan, S.; Nicholls, A.; Alexov, E.; Chiabrera, A.; Honig, B.
Rapid grid-based construction of the molecular surface and the use of induced
surface charge to calculate reaction field energies: Applications to the molecular
systems and geometric objects. J. Comput. Chem. 2002, 23, 128–137.
(64) Baptista, A. M.; Soares, C. M. Some Theoretical and Computational Aspects of
the Inclusion of Proton Isomerism in the Protonation Equilibrium of Proteins. J.
Phys. Chem. B 2001, 105, 293–309.
(65) Karabadzhak, A. G.; Weerakkody, D.; Wijesinghe, D.; Thakur, M. S.; Engelman,
D.M, Andreev, O. A.; Markin, V. S.; Reshetnyak, Y. K. Modulation of the
pHLIP transmem- brane helix insertion pathway. Biophys. J. 2012, 102, 1846–
1855.
(66) Henderson, R.; Baldwin, J. M.; Ceska, T. A.; Zemlin, F.; Beckmann, E.;
Downing, K. H. Model for the structure of bacteriorhodopsin based on highresolution electron cryo- microscopy. J. Mol. Biol. 1990, 213, 899–929.
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Figure 1: Probability density of distance to membrane center of key titrable groups in wtpHLIP at pH 6.0 (A). The membrane region is marked as gray with a dashed line at its
center. For the remaining pH values, see Figure S2 of Supporting Information.
Representative conformation of membrane-inserted state of wt-pHLIP with the titrable
groups highlighted (B). Lipid tails are represented as transparent sticks with P atoms as
grey spheres. pHLIP secondary structure is represented as a dark grey cartoon with key
titrable groups side chains in spheres.

69

Figure 2: Monolayer thickness profiles for wt-pHLIP at pH 6.0. The top monolayer is the
one interacting with Asp14 and the bottom is the one interacting with the C-terminus acidic
residues. For the remaining pH values, see Figure S3 of Supporting Information.
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Figure 3: pKa profile of Asp14 (A) and C-terminus acidic residues (B) along the membrane
normal obtained with CpHMD simulations of wt-pHLIP. The negative insertion values correspond to membrane inserted positions, while positive values correspond to more shallow
locations. The insertion values were measured between the titrable group and the average
position of the selected phosphate groups within a 6 ˚A radius.
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Figure 4: Schematic representation of the pH-dependent mechanism for membrane insertion/withdrawal of L16H pHLIP.
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Figure 5: pKa profiles of Asp14 and His16 along the membrane normal obtained with
CpHMD simulations of L16H pHLIP variant. The unfilled circles in the His16 profile correspond to a deep inserted region for which we did not have enough sampling to compute
the error bars. They are shown to qualitatively illustrate the profile tendency. The negative
insertion values correspond to membrane inserted positions, while positive values
correspond to more shallow locations. The insertion values were measured between the
titrable group and the average position of the selected phosphate groups within a 6 ˚A
radius. For residues at the C-terminus domain see Figure S4 in Supporting Information.
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Figure 6: pH-dependence of the position of the maximum shift of Trp fluorescence spectra
of L16H pHLIP variant (A). The experimental data were fitted using the bi-dose response
module in Origin 2017, to establish cooperativity (n) and mid transition (pKexp). OCD
spectra of L16H pHLIP variant measured on POPC-supported bilayers at pH 2, 4 and 8
(B)
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ABSTRACT
To advance mechanistic understanding of membrane-associated peptide folding and
insertion, we have studied the kinetics of three single tryptophan pHLIP (pH-Low Insertion
Peptide) variants, where tryptophan residues are located near the N terminus, near the
middle, and near the inserting C-terminal end of the pHLIP transmembrane helix. Singletryptophan pHLIP variants allowed us probing different parts of the peptide in the pathways
of peptide insertion into the lipid bilayer (triggered by a pH drop) and peptide exit from the
bilayer (triggered by a rise in pH). By using pH jumps of different magnitudes, we slowed
down the processes, and established the intermediates that helped us to understand the
principles of insertion and exit. The obtained results should also aid the applications in
medicine that are now entering the clinic.

SIGNIFICANCE
The process of peptide insertion across a membrane is of fundamental interest. It also
illuminates our thinking about the ways that lipid boundaries can interact with the
molecules they encounter. Obtained in this study results, combined with our recent
constant-pH molecular dynamics simulations and kinetics experiments with liposomes of
different bilayer thicknesses allowed us to complete a generalized model of the insertion
and folding of polypeptides of the pHLIP family, and expand the general view of peptide
conformations and dynamic excursions of the bilayer that can accompany interactions with
peptides. While the insertion of pHLIPs across membrane bilayers has basic scientific
interest, the possibility of clinical applications for tumor imaging and therapy is also
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emerging as a reality. By understanding the principles of pHLIP properties, the future
applications can be broadened and improved.

INTRODUCTION
pH-Low Insertion Peptides (pHLIPs®1) are being increasingly studied to gain insights
concerning peptide folding and insertion into membranes, and to apply them in medicine.
Because their membrane insertion from a water-soluble state is triggered by pH changes, a
rich opportunity is created for chemical, kinetic and computational studies, as shown by
the expanding literature from a growing number of laboratories and ongoing efforts to use
them as medically useful acidity sensors in vivo. Currently, pHLIPs are being used in
studies of membrane-associated folding and unfolding as a model system (1-10), and in a
variety of biomedical applications for targeted delivery of imaging and therapeutic agents
(11-14). In this paper, we position Tryptophans (Trp) as sensors in the flanking and central
regions of a pHLIP and exploit kinetic analysis to study the pathways of membrane entry
and exit.
Metabolically active cells, like cancer cells and tumor-associated macrophages within
tumors, or activated macrophages in inflamed tissues, are known to acidify their
environments (15-18). The extracellular pH in the vicinity of cells in normal healthy tissue
is about 7.2-7.4, while pH at the surface of cancer cells could be as low as pH 6.0 (19).
Acidity is a possible biomarker for specific targeting of these cells in diseased tissues, but
the extracellular pH is only about one pH unit lower than the extracellular pH in healthy
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organs, creating a challenge for pH-sensitive agents to discriminate between them. A
family of pHLIPs was designed to have a variety of properties while sharing the
characteristic pHLIP insertion into membrane lipid bilayers at low pHs (<pH7.0) (11, 20,
21). A pHLIP’s affinity for a membrane leads to a reversible membrane-adsorbed surface
state at high and neutral pHs, which allows a pHLIP to sense the pH at the surfaces of cells
(1), triggering insertion if the pH is low. Weak surface binding is useful for a pH-sensing
agent, since the pH at the surfaces of cancer cells is 0.5-0.7 pH units lower than the bulk
extracellular pH and independent of tumor (tissue) perfusion (19, 22). Another feature of
the pHLIP delivery system is that these peptides undergo a cooperative coil-helix transition
in response to a pH change, and the pK and cooperativity of the transition are tunable by
sequence variation. Further, the activation barrier for insertion into bilayers can be
adjusted, pre-determining the time required for cellular targeting and insertion (2, 5, 23).
These parameters have utility for pHLIP applications to real biological systems.
To advance understanding of the mechanism of the membrane-associated pHLIP folding
we have extended our kinetics studies of single-Trp pHLIP variants. Observations using
single-Trp variants have allowed us to observe intermediate steps in the pathways of
peptide insertion into the lipid bilayer triggered by a pH drop and the peptide exit from the
bilayer triggered by a rise in pH.

MATERIALS AND METHODS
pHLIP variants were synthesized and purified by CS Bio Co, and tested for purity by HPLC
upon receipt. Small unilamellar vesicles were prepared by extrusion. Steady-state
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fluorescence and circular dichroism (CD) measurements were performed using a PC1
spectrofluorometer (ISS, Inc) and a MOS-450 spectrometer (Biologic, Inc.), respectively,
with temperature control set to 25.0°C. Oriented CD (OCD) measurements were conducted
on the supported bilayers placed on quartz slides using the Langmuir-Blodgett system
(KSV Nima) as described previously (3). Tryptophan fluorescence and CD kinetics were
measured using an SFM-300 mixing system (Bio-Logic Science Instruments) connected to
the MOS-450 spectrometer with temperature control set to 25.0°C. All data were fit to the
appropriate equations by nonlinear least squares curve fitting procedures employing the
Levenberg Marquardt algorithm using Origin 8.5. Detailed descriptions of all methods are
presented in the Supporting Information.

RESULTS
We studied the kinetics of insertion into and exit from the lipid bilayer of POPC liposomes
using three single Trp pHLIP variants, with the Trp reporters positioned in each flanking
region and in the membrane inserted region. pHLIP peptides with a single tryptophan
residue allow a “clean” photophysical signals originating from single fluorophores,
avoiding spectral heterogeneity. pHLIP variants were designed based on the closely related
group of the WT sequences (24), which contains several protonatable residues at the
membrane inserting C-terminal end of the peptide. As we demonstrated previously, the
presence of protonatable groups at the C-terminus of the peptide slows down the process
of insertion of the peptide across a lipid bilayer, as well as slowing exit from the membrane
(2, 3). These processes are completed within seconds, as opposed to milliseconds for
truncated pHLIPs (2), which allows resolution of structural details along the insertion and
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exit pathways. The following single Trp pHLIP variants were designed and used in the
current study:
pHLIP-W6:

ADNNPWIYARYADLTTFPLLLLDLALLVDFDD

pHILP-W17: ADNNPFIYARYADLTTWPLLLLDLALLVDFDD
pHLIP-W30: ADNNPFIYARYADLTTFPLLLLDLALLVDWDD
The length of the designed variants is 32 residues and Trp residues are placed at positions
6, 17 and 30 in the pHLIP sequence in order to be located at the beginning, middle and end
of the peptide in its helical inserted form. Phe was replacing other two Trp residues in each
variant, which considered to be the best possible substitution of Trp. Using these designs,
we can monitor the propagation of different parts of the peptide into and out of the bilayer
by recording the changes of their fluorescence signals within single-Trp pHLIP variants.
First, we performed equilibrium measurements presented in Figures 1 and 2. Steady-state
fluorescence, CD and OCD measurements were used to ensure that each variant is
responsive to pH and adopts a TM helical orientation in a POPC bilayer at low pH, which
is the main feature of the peptides of pHLIP family (Supplementary Figure S1).
Fluorescence spectra were analyzed using the Protein Fluorescence and Structural Tool Kit
(PFAST) to determine the positions of spectral maxima (λmax) (25, 26). The transition from
the membrane-adsorbed state at high pH to the membrane-inserted state at low pH was
assessed from changes of the position of the Trp fluorescence maximum and the ellipticity
measured at 222 nm in response to a pH drop from 8.5 to 4 (Figure 1 and Table 1). Analysis
of Trp fluorescence reveals the presence of two transitions, which are especially noticeable
for the W6 pHLIP variant. The mid-points of the first transition for all variants are
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established to be around pH 6 with high cooperativity (parameter n is from the equation
given in the Supplementary Methods section), ranging from 2.4 to 3.5 for different
pHLIPs. The second transition is found to be around pH 7.2 with a cooperativity of ranging
from 0.5 to 1.6. Interestingly, the CD data reporting the coil-helix transformation are
clearly indicative of a single transition with its midpoint at pH 5.8-5.9 and cooperativity
ranging from 1.8 to 2.4 for the different pHLIP variants. Note that the transition midpoint
is a relatively well defined and stable parameter, while the measured cooperativity is less
well determined and might vary over a relatively wide range within experimental error.
The local changes reported by the Trp locations and the general peptide changes reported
by CD might be expected to vary from each other, since these parameters might reflect
different processes. The high pH transition observed in the fluorescence signal reflects the
protonation-deprotonation event, which might be associated with partitioning of regions of
the peptide into the lipid bilayer, but not directly associated with the coil-helix transition.
The most significant differences occur at the N-terminal part of the pHLIP peptide.
To gain more insight into the locations of Trp residues at different pHs, we carried out Trp
fluorescence quenching measurements (Figure 2 and Table 1). The emission of Trp
residues was measured at different pHs at increasing concentrations of acrylamide, which
is an effective quencher of Trp fluorescence. PFAST analysis was used to calculate SternVolmer constants (25, 26) and to calculate the percentage of quenching. At pH 8 and pH 5
the Stern-Volmer plots for all peptide variants demonstrate linear behavior with some
upward curvature (Figure 2A and 2D). The upward curvature in quenching by acrylamide
was observed before and attributed to the exponential distance-dependent rate of quenching
(27). At intermediate pH of 6 a deviation from linearity is observed (Figure 2C),
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potentially reflecting the existence of different populations of pHLIPs, where Trp residues
are located in different environments and their emission is quenched differently by
acrylamide (28). Figure 2E and Table 1 reflect gradual decreases of acrylamide quenching
of Trp fluorescence with decreases of pH, which can be attributed to the partitioning of Trp
residues into the membrane at lower pH and reduction of accessibility to the quencher. The
smallest quenching among all pHLIP variants at low pH was observed for the W6 pHLIP
variant, reflecting a more solvent-exposed position for Trp6, which correlates well with its
higher long-wavelength emission at low pH compared to Trp17 and Trp30.
Insertion and exit kinetics measurements were triggered by a pH drop from 8 to 4 and a pH
raise from 4 to 8, respectively (Supplementary Figure S2). Prior to the pH shift, peptide
(14 μM) and POPC (2.8 mM) samples were incubated for 24 hrs to reach equilibrium,
when most of the peptide is associated with the liposomes (1). As we found previously, the
peptide exit from the membrane is much faster than the insertion into the membrane (2, 3).
All (or most) protonatable residues in the TM part and at the inserting end of the peptide
need to be protonated and became neutral to enter the lipid bilayer, which takes time. On
the other hand, the de-protonation of Asp13 may be enough to induce helix destabilization
and peptide exit (4), especially when the C-terminal end of the inserted peptide is in its
neutral state due to the fast equilibration of the pH established between the exterior and
interior of the liposomes after the pH drop (2). Some differences were observed between
variants for the insertion and exit kinetics.
To slow down the kinetic processes and enhance the observed differences we also used
intermediate pH jumps: from pH 8 to 5.9-6.2 and from pH 4 to 5.8-6.2, monitoring changes
of the fluorescence intensity and the position of maxima of fluorescence spectra during
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peptide insertion and exit. The changes of fluorescence were recorded at different
wavelengths in a global mode, and fluorescence spectra were restored by data processing
(Supplementary Figure S3 presents data obtained for Trp30 as an example). Changes of
Trp emission intensity recorded at different intermediate pH jumps are shown on Figure 3.
The rates of peptide insertion decrease with decreases of the magnitudes of the pH jumps,
and the differences in kinetics pathways between variants become more pronounced
(Figure 3 A-C). Trp6 exhibits insertion kinetics with a reversal “kink” where the
fluorescence signal first increases, then decays around 15-20 sec after the initiation and is
then followed by an emission increase (Figure 3A and 4A). Trp17 reaches its final
destination in the membrane rather quickly (Figure 3B). The insertion of Trp30 into the
membrane occurs on the time scale of Trp6 and Trp17 insertions. The presence of a “kink”
for Trp6 was also observed in the kinetics of the CD signal (Figure 4A) and on the graph
of the intensity ratio (Figure 4B) from the fluorescence spectra recorded in the global mode.
The ratio is a sensitive measure of the shift of the position of the emission maximum of
W6 pHLIP variant insertion. A “kink” was also observed for the Trp30 insertion kinetics
by monitoring intensity changes (Figure 4C) and using the intensity ratio (Figure 4D). The
data clearly indicate that the propagation of pHLIP peptides into the membrane are
associated with a series of changes in the microenvironments of the Trp residues.
The most interesting behavior during the exit of pHLIP variants was observed for Trp30
(Figure 3F and Figure 5). The fluorescence intensity first increased, then was followed by
signal decay. The time of the increasing signal was shifted from 1.5 sec in the case of pH
jump from pH 4 to 5.8 to 0.4 sec in the case of pH jump from pH 4 to 6.2 (with an
intermediate time of 0.92 sec - for the pH jump from 4 to 6.0). While the build up, which
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is completed within <2 sec, is difficult to resolve in the global mode, the overall intensity
decay (Figure 5B) correlates with the 333 nm to 351 nm ratio of emission. As with the
insertion measurements, the exit kinetics reveal subtle features not previously observed.

DISCUSSION
To gain understanding of how a peptide can enter and leave a lipid bilayer, we used the
pH-triggered insetion and exit of three single-Trp pHLIP variants. We would like to outline
that the study is a model biophysical and extreme pHs are set to observe completion of the
transitions. Previously it was shown direct correlation between biophysical studies,
experiments on cells for delivery of cargo molecules by pHLIP and animal studies for
targeting of acidic tumors (23, 24). We found a previously unknown transition at high pH
values that is especially pronounced for the N-terminal part of pHLIP. The transition
correlates with our recent constant-pH molecular dynamics (MD) calculations, which
suggest a high flexibility of the N-terminal flanking sequence of pHLIP (4). At different
pH values in the range of 8.5 to 6.5, pHLIP can adopt various conformational states at a
bilayer surface, as was noticed previously (6, 8). These conformational changes are not
associated with helix formation. A further drop of pH induces the familiar bilayerassociated coil-helix transition, leading to the stabilization of the TM helix at low pH. Trp
residues at positions 6 and 30 in the pHLIP sequences adopt similar, partially exposed
positions within the lipid bilayer at the outer and inner leaflets, respectively, after peptide
insertion, while Trp at position 17 is located near the center. Acrylamide quenching of Trp
fluorescence confirmed single component emission at high and low pHs, when peptides
are predominantly equilibrated in the inserted or bilayer-adsorbed states, but heterogeneity
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was observed at intermediate pH of 6. By monitoring signals from single-Trp pHLIP
variants, we were able to resolve ambiguities created by the interplay of signals from the
two Trps in the WT peptide (9).
By using pH jumps of different magnitudes, we found intermediates that help us to better
understand the principles of insertion and exit. If the pH jump is large enough, e.g. a
change from pH8 to pH4, it can simultaneously protonate all (or most) of the protonatable
residues in the membrane inserting part, and the peptide quickly inserts in a TM orientation.
We previously found that truncation of the C-terminal, inserting part of WT pHLIP can
enhance the rate of insertion by two orders of magnitude, revealing that protonated but still
polar C-terminal carboxyl groups can pose a significant barrier for transit of the C-terminus
across the bilayer, but that entry can still proceed on a timescale of seconds (2, 23).
However, if the pH jump is to an intermediate value, the concentration of protons in
solution is not enough to fully shift the equilibrium toward the protonated form of residues
at the C-terminal part of the peptide, and the peptide is trapped into intermediate states. At
intermediate pH jumps N- and C-terminal parts of pHLIP alter their positions toward the
bilayer center, while Trp17 adopts a position deep within the membrane rather quickly, as
would be consistent with a bent but not inserted conformation. The insertion is completed
slowly, consistent with a requirement that protonation of most of the Asp/Glu residues is
needed for peptide insertion to proceed at a significant rate. As suggested by MD
calculations, and as reasonably expected from the progressively lower dielectric
environment, the pKa of protonation is shifted toward higher values as Asp, Glu and the
C-terminus move deeper into the bilayer (4).
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As previously reported, the exit pathway resulting from a pH raise is different from the
pathway of insertion (3). Changes in emission of tryptophan at the C-terminal part of
pHLIP sequence (Trp30) during exit add to our understanding of the process, in which an
increase of pH leads to the de-protonation of key Asp residues, destabilizing the bilayerinserted state, and triggering peptide exit. We observed an increase or “build up” of the
fluorescence signal, followed by its decay, which clearly documents the exposure of Trp30
to the non-polar bilayer environment along the pathway of peptide exit from the bilayer.
The propagation of the C-terminal part of pHLIP through the membrane slows down with
a decrease of the magnitudes of the pH jumps.
We believe that our kinetics study, together with recent kinetics experiments on liposomes
of different thickness of bilayer (5), theoretical (29) and computational (4) work, frames
an improved understanding of the mechanism of pHLIP peptide insertion and exit from a
bilayer in response to pH jumps. Figure 6 represents the general scheme of the processes
as we now understand it. The membrane-adsorbed state is defined as predominantly
unstructured (extended coil) with the C-terminus facing to the outside of a liposome (or
extracellular space). The exact position of the peptide at the surface of the bilayer at high
and neutral pH depends on the pHLIP sequence and lipid composition (6, 7, 24, 30). The
inserted state is characterized by a transmembrane orientation of the peptide, with the Cterminal end of the peptide facing the liposome interior (or intracellular space). The
transition from membrane-adsorbed to inserted states is triggered by pH, which leads to
the protonation of at least some Asp and Glu residues, increase of peptide hydrophobicity,
deeper partition into bilayer associated with coli-helix transition. We now recognize a set
of possible intermediate states, characterized by partially folded structures at the bilayer
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surface, where the C-terminus is not translocated across the bilayer. The number and nature
(transient, semi-stable or stable) of intermediate states is dependent on the number of
protonatable groups or polar (charged) cargoes located at the peptide inserting end (2).
Charged (or polar) residues and cargoes create forces directed away from the bilayer, which
reduces the rate of peptide insertion. As we proposed (2) and recently verified (5), the
predominant driving force for the transition from the helical surface intermediate state to
the stable membrane inserted state is a relaxation of the membrane distortion created by
the inclusion of helical structure at the bilayer surface. The presence of helical instability
around the Pro residue in the middle of the helix provides additional flexibility to complete
the transition toward a TM orientation. Figure 6 is not a simplified two-state model, it is a
generalized model to include the behaviors of various pHLIP sequences within membranes
of different lipid compositions.
Recently, a multistage model of WT-pHLIP insertion with distinct equilibrium
thermodynamic intermediates has been proposed (8). While it is interesting to think there
is a linear progression of states, the fact is that an ensemble of all peptide states exists at
each pH, so it remains challenging to define a unique succession. At high and low pH
values the predominant, but still not unique states are the peptide membrane-adsorbed and
membrane-inserted states, respectively, each of which has a variety of dynamic excursions.
However, at intermediate pH values a more distributed mixture of states is present as can
be seen in the kinetics measurements, and complexity is shown by the reversal of the
fluorescence signal. Of course, in a biological system of living cells in diseased tissues, pH
gradients exist across cell membranes, with a low pH at the outside surface of a cell and a
higher pH in the cytoplasm (31). In a tumor cell , the pH at the cell surface can be below
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6 while the pH inside the cell is thought to be around 7.4. The pH gradient tends to stabilize
the inserted state, since any C-terminal protonatable residues translocated across the
membrane into the cytoplasm will be relatively de-protonated in the environment of the
normal pH of the cytoplasm, which leads to a significant reduction of the rate of peptide
exit from the membrane.
Thermodynamics is not limiting for the intracellular delivery of cargo conjugated to pHLIP
C-terminal inserting end, since the equilibrium of the pHLIP peptide in a cell with an
acidic diseased phenotype will be as a TM helix and the chemical potential of the cargo
will be about the same on either side of the membrane. Given enough time for equilibration,
even polar or charged cargoes could be delivered into cells and trapped in the cytoplasm.
However, in a living biological system the circulatory and other dynamics will tend to
remove uninserted pHLIP complexes, so the kinetics of insertion becomes an important
factor for tumor targeting and cargo delivery. Since pHLIPs have a significant affinity for
bilayer surfaces, they sense the pH at the surfaces of cells in diseased tissues, and when pH
is low, pHLIPs insert into cellular membrane. The rate of insertion depends on several
factors: i) the level of acidity in the vicinity of cell membrane; ii) number of polar/charged
residues at the membrane-inserting end of the peptide and/or polarity/charge of cargo
molecule (if any), which peptide is translocating (flipping) across membrane, and iii)
composition, thickness and fluidity of membrane (2, 5).
While the insertion of pHLIPs across membrane bilayers is of basic scientific interest, the
possibility of clinical applications for tumor imaging and therapy is emerging as a reality.
Clinical trials for applications to the targeting of imaging agents are about to start, with the
first patients being scheduled at the time of this writing, and trials based on targeting tissues

89

with a therapeutic agent are anticipated in 2020. By understanding the principles of pHLIP
properties, it is likely that future applications can be broadened and improved.
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TABLES
Table 1. Tryptophan emission parameters obtained from steady-state fluorescence and CD
measurements (mean ± standard deviation) are presented. The tryptophan fluorescence
spectra were processed by PFAST to identify positions of spectral maxima (max). Values
of max were averaged over several different steady-state fluorescence measurements. The
parameters representing transitions induced by a pH drop from 9 to 3, including the
midpoint of the pH transition (pK) and cooperativity (n), were calculated by fitting values
of the position of maximum of fluorescence (Fluor) and ellipticity at 222 nm (CD)
measured at different pHs.

The Stern-Volmer constants (KSV, M-1) for acrylamide

quenching of tryptophan fluorescence of peptides in POPC liposomes at different pHs were
obtained after PFAST analysis of fluorescence spectra.

W6

W17

W30

max, pH8 (nm)

349.5 ± 0.4

349.2 ± 0.3

352.1 ± 0.4

max, pH8 + PC (nm)

347.9 ± 0.9

346.9 ± 0.8

350.4 ± 0.3

max, pH5 + PC (nm)

340.4 ± 0.7

332.3 ± 1.6

339.7 ± 0.9

Fluor, pK1

6.0 ± 0.0

6.0 ± 0.0

6.1 (fixed)

Fluor, n1

3.5 ± 0.3

2.6 ± 0.1

2.4 ± 0.2

Fluor, pK2

7.2 ± 0.1

7.3 ± 0.1

7.2 (fixed)

Fluor, n2

1.6 ± 0.4

1.2 ± 0.4

0.5 ± 0.1

CD, pK

5.9 ± 0.0

5.8 ± 0.0

5.8 ± 0.0

CD, n

2.2 ± 0.2

2.4 ± 0.2

1.8 ± 0.2

Ksv, pH7.9-8.1 PC (M-1)

20.5 ± 3.5

20.1 ± 2.1

21.2 ± 3.9

Ksv, pH7.0-7.3 PC (M-1)

19.3 ± 0.5

18.2± 1.1

18.1 ± 0.4

Ksv, pH5.9-6.2 PC (M )

8.0 ± 0.6

11.6 ± 1.7

12.6± 0.7

Ksv, pH4.8-5.0 PC (M-1)

6.2 ± 0.9

2.4 ± 0.1

2.9 ± 0.2

-1
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FIGURE LEGENDS
Figure 1. pH-dependent bilayer insertion of pHLIP variants. The pH-dependent
insertion of W6 (A and D), W17 (B and E) and W30 (C and F) pHLIP variants into the
lipid bilayers of POPC liposomes was studied by monitoring the changes in the position of
maxima of tryptophan fluorescence spectra (A-C) and ellipticity of CD signals measured
at 222 nm (D-F) as function of pH. The data were fitted using the Henderson-Hasselbalch
equation, the fitting curves and 95% confidence interval are shown by red and pink areas,
respectively.

Figure 2. Acrylamide quenching. Quenching of tryptophan fluorescence of W6, W17 and
W30 pHLIP variants in presence of POPC liposomes at the range of pH values: pH7.9-8.1
(A), pH7.0-7.3 (B), pH5.9-6.2 (C), pH4.8-5.0 (D) are presented. The percentage of
quenching at different pHs calculated for different pHLIP variants is shown in panel E,
assuming quenching of tryptophan in solution by acrylamide (21 M-1) to be 100%.

Figure 3. Kinetics of insertion and exit. Representative kinetic curves for the insertion
(A-C) of W6 (A, D), W17 (B, E) and W30 (C, F) pHLIP variants into the lipid bilayer
triggered by drops of pH from pH8 to pHs 5.8, 6.0 and 6.2, and for the exit (D-F) of W6
(A, D), W17 (B, E) and W30 (C, F) pHLIP variants out of the lipid bilayer triggered by
raises of pH from pH4 to pHs 5.8, 6.0 and 6.2 are shown. The normalized fluorescence
measured via 320 cut off filter is presented.
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Figure 4. Kinetics of insertion. Representative kinetic curves for the insertion of W6 (A,
B) and W30 (C, D) pHLIP variants into the lipid bilayer triggered by drops of pH from
pH8 to pH5.8-5.9, and from pH8 to pH6.2, respectively, are shown. The peptides insertion
was monitored by changes of fluorescence intensity (A, C) and ratios of fluorescence
measured at different wavelengths in the global mode kinetics experiments (B, D). The W6
pHLIP variant folding and unfolding was monitored by changes of the CD signal (A). Red
curves in panels B, C and D represent averages of the measured signal shown in black.

Figure 5. Kinetics of exit. Representative kinetic curves for the exit of the W30 pHLIP
variant from the lipid bilayer triggered by raises of pH from pH4 to pHs 5.8, 6.0 and 6.2
are shown. The peptide exit from the membrane was monitored by changes of fluorescence
intensity (A, B) and ratio of fluorescence measured at different wavelengths in global mode
kinetics experiments (C). Red curve at panel C represents averaged of the measured signal
shown in black.

Figure 6. Model of pHLIP insertion and exit. Schematic presentation of pHLIP folding
and insertion into a bilayer, as well as the pHLIP exit and unfolding are shown.
Approximate locations of Trp6, Trp17 and Trp30 are shown by green, blue and yellow
colors, respectively. The structure of WT pHLIP in the membrane-inserted state was taken
from the results of MD simulations (15).
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Supporting Information
METHODS
Peptide Preparation
Peptides were synthesized and purified by CSBio (Menlo Park, CA). Purified peptides
were dissolved in 6 M urea and passed through a G-10 size exclusion spin column to
transfer to 10 mM phosphate buffer, pH 8. Peptide concentrations were calculated using
absorbance measurements at 280 nm, where 𝜀280 = 8,520𝑀−1 ∙ 𝑐𝑚−1.
Liposome Preparations
Small unilamellar vesicles were prepared by extrusion. 1-Palmitoyl-2-oleoyl-sn-glycero3-phosphocholine (POPC, Avanti Polar Lipids, Inc.) dissolved in chloroform at a
concentration of 12.5 mg/ml was desolvated in a rotary evaporator to create a phospholipid
film and placed under high vacuum for 2 hours. Lipids were then rehydrated in phosphate
buffer (pH 8) and extruded through membranes with pore size of 50 nm. The liposome size
distribution was measured using a nanoparticle tracking system, Nanosight (NS300,
Malvern).
EQUILIBRIUM MEASUREMENTS
Steady-State fluorescence and CD
All steady-state spectral measurments including fluorescence, circular dichroism (CD),
oriented CD (OCD), pH-dependence and acrylamide quenching were performed using a
PC1 spectrofluorometer (ISS, Inc) and a MOS-450 spectrometer (Biologic, Inc with
temperature control set to 25.0°C. Tryptophan fluorescence spectra were recorded from
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310 to 390 nm with step of 1 or 2 nm using an excitation wavelength of 295 nm. Excitation
and emission polarizers were set to 54.7° and 0.0°, respectively. CD and OCD spectra were
recorded from 195 to 260 nm with step of 1 nm. The concentration of peptide and
liposomes were 7 μM and 1.4 mM, respectively.
Oriented CD
OCD measurements were conducted on supported bilayers deposited on quartz slides using
a Langmuir-Blodgett system (KSV Nima). Fourteen slides were cleaned using the
following protocol; sonication for 10 min in cuvette cleaner solution (5% Contrad in
water), 2-propanol, acetone, 2-propanol, followed by rinsing in deionized water. Finally,
the slides were immersed in a mixture of concentrated sulfuric acid and hydrogen peroxide
(3:1 ratio) for 5 min to remove any remaining organic material and then rinsed three times
in deionized water. The slides were stored in deionized water until the monolayers were
applied. The POPC monolayers were deposited on the quartz slides using a KSV
minitrough. For the Langmuir-Blodgett system, POPC dissolved in chloroform solution at
3 mg/ml was spread on subphase. After allowing chloroform to evaporate, the POPC
monolayer was compressed to 32 mN/m. The initial layers on the slides were deposited by
retrieving the slide from the subphase at a rate of 15 mm/min, and the second layer was
added by introducing a solution of 10 μM peptide and 1 mM POPC liposomes (50-nm in
size) at pH 4, resulting in the creation of the supported bilayer via fusion of one layer with
liposomes. After incubation for 6 h at 100% humidity, excess vesicles were carefully
removed, buffer at pH 4 was added to the spaces between slides, and the slides were stacked
with 0.2-mm spacers. CD measurements were taken at three time points: immediately after
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the addition of the peptide/liposome solution (0 h), after 6 h and 12 h of incubation time
(6 h and 12 h).
pH dependence
The pH-dependent insertion of the peptides into the lipid bilayer of liposomes was studied
by monitoring either the changes in tryptophan fluorescence spectra or changes in the molar
ellipticity at 222 nm as a function of pH. After the addition of aliquots of citric acid, the
pHs of solutions containing 7 μM peptide and 1.4 mM POPC liposomes were measured
using an Orion PerHecT ROSS Combination pH Micro Electrode and an Orion Dual Star
pH and ISE Benchtop Meter before and after each spectrum measurement to ensure that
equilibrium is achieved. The tryptophan fluorescence at each pH was measured on a PC1
spectrofluorometer. Fluorescence spectra were analyzed using the Protein Fluorescence
and Structural Tool Kit (PFAST) to determine the positions of spectral maxima (λmax).
Finally, λmax or millidegree were plotted as a function of pH. The pH-dependence was fit
with the Henderson-Hasselbach equation (using OriginLab software) to determine the
cooperativity (𝑛𝑖 ) and the mid-point (𝑝𝐾) of a single or two transitions:
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑𝑝𝐻𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑐𝑒 =

1
1+10𝑛𝑖 (𝑝𝐻−𝑝𝐾𝑖 )

Acrylamide quenching
Tryptophan fluorescence quenching experiments were conducted using acrylamide in the
cuvette of 3 x 3 mm. Solutions containing 7 μM of pHLIP peptides and 1.4 mM of POPC
liposomes were adjusted to about pH 8, 7, 6, or 5. Tryptophan fluorescence quenching was
achieved by addition of increasing amounts of acrylamide. Different amounts of
acrylamide used for different pH values (the maximum was 0.2-0.3 M of acrylamide for
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measurements performed at low pH). The obtained data were corrected for the dilution and
inner filter effect taking into account that the exctiction coefficient for acrylamide at 295
nm is 0.25 M-1cm-1. PFAST analysis was employed to calculate Stern-Volmer constants
and to calculate the percentage of quenching (100% was assigned to the quenching of
tryptophan in solution, KSV = 21 M-1).
Kinetics Measurements
Tryptophan fluorescence and CD kinetics were measured using a SFM-300 mixing system
(Bio-Logic Science Instruments) in combination with the MOS-450 spectrometer with
temperature control set to 25.0°C. All samples were degassed before measurements to
minimize air bubbles in the samples. Peptide (14 μM) and POPC (2.8 mM) samples were
incubated for 24 hrs to reach equilibrium, when most of the peptide is associated with
liposome lipid bilayers. To follow peptide insertion, equal volumes of peptide-POPC
solution and citric acid were fast mixed (5-ms dead time) to lower the pH from pH 8 to the
desired lower pH value. To measure peptide exit, equal volumes of peptide-POPC solution
and disodium phosphate were mixed to raise the pH from pH 4 to the desired higher pH
value. To monitor fluorescence intensity changes during peptide insertion or exit, the
tryptophan emission signal was observed through a cut off 320 nm filter at an excitation of
295 nm. To monitor the shift of the entire tryptophan spectra of the peptides during
insertion and exit, (excited at 295 nm) an emission monochromator was used. In the latter
case, fluorescence kinetics spectra were recorded in a global mode at individual emission
wavelengths from 321 nm to 366 nm with steps of 3 nm. Three-dimensional plots were
constructed reflecting changes in fluorescence intensity, time, and wavelength. Twodimensional plots were made by taking cross sections at particular times and plotting
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intensity vs. wavelength. To monitor coil-helix transition (and vice versa) the CD signal at
222 nm was recorded.
Data analysis
All data were fit to the appropriate equations by nonlinear least squares curve fitting
procedures employing the Levenberg Marquardt algorithm using Origin 8.5.

FIGURES

Figure S1. Tryptophan fluorescence (A-C), CD and OCD (D-F) spectra are shown from
Trp6 (A, D), Trp17 (B, E) and Trp30 (C, F) pHLIP variants: in aqueous solution at pH 8
(black lines), at pH8 in the presence of POPC liposomes (blue lines) and at pH4 in the
presence of POPC liposomes (red lines). Oriented circular dichroism (OCD) signals
measured at low pH in supported bilayers are shown in panels D-F (green curves).
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Figure S2. Trp fluorescence kinetics measurements of pHLIP peptide insertion and exit
are shown over different time scales for Trp6 (black lines), Trp17 (blue lines), and Trp30
(red lines) pHLIP variants. Insertion is triggered by a pH jump from pH8 to pH4 (A, B)
and exit by a pH jump from pH4 to pH8 (C, D).
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Figure S3. 3D (A, C) and 2D (B, D) representations are shown for the insertion (A, B) and
exit (C, D) kinetics of Trp30, on the inserting C-terminal flank of the pHLIP peptide.
Spectral regions of the fluorescence reveal complex pathways, as in the short wavelengths
for insertion seen in A.
The 3D plots (A, C) reflect changes in fluorescence intensity, time, and wavelength (the
axis are the same on both panels, but angle views are different for better presentation). The
2D plots (B, D) show cross sections of the 3D plots at selected time points.
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